{"study_id": 112162, "supplement_id": 901, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the placebo effect of avocado soya bean extract compared to other therapies in reducing pain intensity in adult patients with temporomandibular disorder (TMD)-related pain.", "results_summary": "The study found that avocado soya bean extract had a significant placebo effect, reducing pain intensity by 36 mm, ranking second highest among the therapies analyzed. The placebo effect for avocado soya bean extract was comparable to other interventions, contributing to pain relief in TMD patients.", "population_specificity": "Adult patients (over 18 years) diagnosed with painful TMD using Research Diagnostic Criteria (RDC/TMD) or Diagnostic Criteria (DC/TMD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:16.256279+00:00"}
{"study_id": 112164, "supplement_id": 901, "safety_score": "90", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of avocado intake on cardiovascular disease (CVD) risk through a systematic review and meta-analysis.", "results_summary": "Avocado intake significantly increased HDL cholesterol but showed no significant difference in serum total cholesterol, LDL cholesterol, triglycerides, or other CVD-related outcomes. No studies reported clinical CVD outcomes like myocardial infarction or stroke.", "population_specificity": "481 subjects across 18 eligible studies (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:16.380867+00:00"}
{"study_id": 112160, "supplement_id": 901, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 65, "study_goal": "The researchers aimed to compare transcutaneous carbon dioxide (TcCO2) values in avocados to those in human controls and other fruits/vegetables.", "results_summary": "Avocados showed TcCO2 values similar to healthy human controls (4.29\u200a\u00b1\u200a0.44\u200akPa vs. 4.34\u200a\u00b1\u200a0.37\u200akPa), with no statistically significant difference (P\u200a=\u200a0.77). Nonroot, nontuberous vegetables like avocados and bell peppers had TcCO2 readings comparable to humans, while fruits had lower values.", "population_specificity": "Avocado samples (Persea americana) and human controls (healthcare professionals).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:16.388481+00:00"}
{"study_id": 112163, "supplement_id": 901, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether replacing carbohydrate energy with avocado-derived fats and fibers enhances satiety compared to a low-fat control meal.", "results_summary": "The study found that consuming a whole avocado (WA) significantly enhanced hunger suppression compared to the control meal (CON), with higher fiber and fat content contributing to improved satiety.", "population_specificity": "Thirty-one overweight/obese adults.", "effective_dosage": "Half avocado (68 g) or whole avocado (136 g) in a single meal.", "study_duration": "6-hour crossover trial per meal.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:16.447852+00:00"}
{"study_id": 112152, "supplement_id": 901, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to identify the top 10 research priorities for infertility, including male infertility, female and unexplained infertility, medically assisted reproduction, and ethics, access, and organization of care.", "results_summary": "The study identified diverse research priorities for infertility, emphasizing prevention, treatment, and long-term impacts, but did not specifically address avocado's effects.", "population_specificity": "Healthcare professionals, people with fertility problems, and other stakeholders from 40 countries.", "effective_dosage": "Not available", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:18.948811+00:00"}
{"study_id": 112166, "supplement_id": 901, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the impact of avocado consumption on plasma lipoprotein levels (TC, LDL-C, HDL-C, and TG) through a meta-analysis of randomized clinical trials.", "results_summary": "Avocado consumption significantly reduced TC, LDL-C, and TG levels, while HDL-C showed a nonsignificant decrease. The study concluded that substituting dietary fats with avocados is beneficial for lipid profile optimization.", "population_specificity": "People at risk for cardiovascular diseases (n = 229 across 10 studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:19.466142+00:00"}
{"study_id": 112167, "supplement_id": 901, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the efficacy of avocado and soya beans extracts (ASE) as a treatment for Lichen sclerosus et atrophicus (LSA) and compare it with other therapies.", "results_summary": "Avocado and soya beans extracts (ASE) showed improvement in lesions and reduced itching in early-stage LSA patients, with 88% of patients experiencing benefits. It was well-tolerated and improved mucosal texture.", "population_specificity": "Patients with Lichen sclerosus et atrophicus (LSA), primarily affecting the anogenital area.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:22.260424+00:00"}
{"study_id": 112171, "supplement_id": 901, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of avocado soybean unsaponifiables (ASU) on insulin secretion and insulin sensitivity in obese patients.", "results_summary": "The study found no significant difference in insulin secretion or insulin sensitivity with ASU administration compared to placebo after 3 months. Both groups showed similar clinical and laboratory characteristics at baseline.", "population_specificity": "14 obese adult volunteers", "effective_dosage": "300 mg of ASU", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:23.451593+00:00"}
{"study_id": 112169, "supplement_id": 901, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effect of avocado fruit extracts on inhibiting the growth of cancer cells (esophageal squamous cell carcinoma and colon adenocarcinoma) compared to normal cells.", "results_summary": "Avocado fruit extracts significantly inhibited the growth of cancer cells compared to normal cells (P<0.05), with phytochemicals playing a key role in this effect. The study suggests avocado extracts could be complementary treatments for esophageal and colon cancers.", "population_specificity": "Esophageal squamous cell carcinoma and colon adenocarcinoma cell lines, as well as peripheral blood mononuclear cells (normal cells).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:24.763701+00:00"}
{"study_id": 112170, "supplement_id": 901, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of two antiplatelet treatments (150 mg ASA vs. 75 mg clopidogrel) on inflammatory markers in type 2 diabetes mellitus (T2DM) patients with high platelet reactivity (HPR).", "results_summary": "Clopidogrel was a positive predictor for reducing sCD40L, while 150 mg ASA was a positive predictor for reducing IL-6. No significant differences were found between treatments for hsCRP or TNF-\u03b1.", "population_specificity": "T2DM patients with high platelet reactivity (HPR) on chronic ASA therapy.", "effective_dosage": "150 mg ASA daily or 75 mg clopidogrel daily.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:25.167837+00:00"}
{"study_id": 112168, "supplement_id": 901, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to determine the effects of daily avocado consumption on cardiovascular disease (CVD) risk factors, particularly LDL cholesterol and related lipid profiles, compared to other cholesterol-lowering diets.", "results_summary": "The study found that including one avocado per day in a moderate-fat diet significantly reduced LDL-C, non-HDL cholesterol, LDL particle number, and small dense LDL cholesterol more effectively than other cholesterol-lowering diets. The avocado diet also improved the LDL/HDL ratio, suggesting additional cardiovascular benefits beyond its fatty acid profile.", "population_specificity": "45 overweight or obese participants with baseline LDL-C in the 25th to 90th percentile.", "effective_dosage": "One fresh Hass avocado (136 g) per day.", "study_duration": "5 weeks per diet intervention.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:25.483891+00:00"}
{"study_id": 112172, "supplement_id": 901, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate variability in platelet reactivity and identify predictors of high platelet reactivity in patients with type 2 diabetes (DM2) treated with oral antidiabetic drugs and chronic acetylsalicylic acid (ASA) therapy.", "results_summary": "The study found poor agreement between different platelet function tests, with 9.9% of patients meeting criteria for high platelet reactivity. Independent predictors of high platelet reactivity included chronic heart failure, current smoking, and higher leukocyte count.", "population_specificity": "171 patients with type 2 diabetes (DM2) treated with oral antidiabetic drugs and long-term ASA therapy.", "effective_dosage": "75 mg of ASA daily.", "study_duration": "Long-term (specific duration not mentioned).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:27.661352+00:00"}
{"study_id": 112173, "supplement_id": 901, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether doubling the dose of acetylsalicylic acid (ASA) improved platelet reactivity in type 2 diabetes patients with high platelet reactivity (HPR) despite treatment with 75 mg of ASA.", "results_summary": "Doubling the ASA dose significantly prolonged collagen/epinephrine-induced closure time (CEPI-CT) and reduced serum thromboxane B2 levels, indicating improved platelet reactivity, though other platelet function tests showed no significant changes. The study concluded that increasing the ASA dose was effective in addressing HPR in these patients.", "population_specificity": "Type 2 diabetes patients with high platelet reactivity despite treatment with 75 mg of ASA.", "effective_dosage": "150 mg of ASA (doubled from the initial 75 mg dose).", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:28.837352+00:00"}
{"study_id": 112174, "supplement_id": 901, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers were examining the effects of an avocado-rich diet on cardiovascular disease prevention, as part of an ongoing trial.", "results_summary": "The abstract does not report specific results for avocado, as the ongoing trial is still examining its provision. The broader study found limited evidence that advice to increase fruit and vegetable intake had favorable effects on CVD risk factors.", "population_specificity": "Healthy adults or those at high risk of CVD.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:29.578033+00:00"}
{"study_id": 112175, "supplement_id": 901, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the bioactivity and functional properties of avocado seeds, focusing on their potential health benefits and applications.", "results_summary": "The study found that avocado seeds may improve hypercholesterolemia, hypertension, inflammatory conditions, and diabetes, and possess insecticidal, fungicidal, and antimicrobial activities. The seeds are rich in phenolic compounds, which may contribute to these effects.", "population_specificity": "Not specified (general review of existing data).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:31.020483+00:00"}
{"study_id": 112165, "supplement_id": 901, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effectiveness of an avocado-soybean unsaponifiable extract (ASU) in reducing pain and improving quality of life in patients with arthralgia and osteoarthritis of the temporomandibular joint (TMJ).", "results_summary": "The study found that ASU extract significantly reduced pain symptoms, improved quality of life, and decreased the use of rescue medication compared to placebo in patients with TMJ osteoarthritis and arthralgia.", "population_specificity": "Fourteen women diagnosed with arthralgia and osteoarthritis of the TMJ using the Research Diagnostic Criteria for Temporomandibular Disorders.", "effective_dosage": "Not specified", "study_duration": "4 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:31.237329+00:00"}
{"study_id": 112177, "supplement_id": 901, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the effectiveness and potential mechanisms of avocado-soybean unsaponifiable fractions and other nutrients in managing osteoarthritis.", "results_summary": "The abstract suggests that avocado-soybean unsaponifiable fractions, among other nutrients, may have potential for improving symptoms and modifying the degenerative process in osteoarthritis, but specific results for avocado alone are not detailed.", "population_specificity": "Elderly individuals with osteoarthritis (general mention, not specific to avocado).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:32.532756+00:00"}
{"study_id": 112176, "supplement_id": 901, "safety_score": "90", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to assess whether avocado-soybean unsaponifiable-Expanscience (ASU-E) could slow radiographic progression in symptomatic hip osteoarthritis.", "results_summary": "The study found no significant difference in mean joint space width (JSW) loss between ASU-E and placebo groups, but ASU-E reduced the percentage of \"progressors\" (those with JSW loss \u22650.5 mm) by 20%. No clinical outcome differences were observed, and safety was excellent.", "population_specificity": "Patients with symptomatic hip osteoarthritis (aged 35-84, 54% women, mean BMI 27 kg/m\u00b2).", "effective_dosage": "300 mg/day", "study_duration": "3 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:33.637303+00:00"}
{"study_id": 112178, "supplement_id": 901, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the stability of avocado oil and olive oil under drastic heating conditions, focusing on saponifiable and unsaponifiable fractions, fatty acid composition, phytosterols, TBARs, and vitamin E content.", "results_summary": "Avocado oil showed higher PUFA/SFA and \u03c9-6/\u03c9-3 ratios than olive oil throughout the experiment, was richer in total phytosterols, and exhibited similar stability to olive oil under heating. Olive oil had higher vitamin E initially, but it degraded faster in avocado oil.", "population_specificity": "Not specified (in vitro study on oils)", "effective_dosage": "Not specified", "study_duration": "Up to 9 hours of heating at 180\u00b0C", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:35.047407+00:00"}
{"study_id": 112180, "supplement_id": 901, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine if a Video Doctor intervention improved dietary behaviors, including increased intake of avocado, among pregnant women.", "results_summary": "The study found that the Video Doctor group significantly increased their intake of avocado, among other healthy foods, compared to the usual care group, which showed no changes. The intervention also improved overall nutrition knowledge and clinician-patient discussions about diet.", "population_specificity": "Ethnically diverse, low-income, English-speaking pregnant women.", "effective_dosage": "Not specified", "study_duration": "Twice during pregnancy (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:36.920316+00:00"}
{"study_id": 112179, "supplement_id": 901, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were examining the association between latex allergy and food allergies, including avocado, in specific high-risk populations.", "results_summary": "The study identified avocado as one of the foods associated with an increased risk of latex allergy sensitization, particularly in healthcare workers and individuals with certain medical conditions. No specific effects or outcomes related to avocado consumption were detailed.", "population_specificity": "Healthcare workers, individuals with spina bifida, myelodysplasia, and those with food allergies (including avocado).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:37.290629+00:00"}
{"study_id": 112181, "supplement_id": 901, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy of avocado/soybean unsaponifiables (ASU) in managing osteoarthritis (OA) by synthesizing preclinical and clinical evidence.", "results_summary": "ASU demonstrated good evidence of efficacy in OA, showing anti-catabolic and anti-inflammatory effects in preclinical studies and clinical data. It was the only studied ingredient with strong clinical support, though its formulation is considered a drug in some countries.", "population_specificity": "Individuals with osteoarthritis (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:37.791756+00:00"}
{"study_id": 201884, "supplement_id": 901, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of acute avocado pulp intake on cardiovascular and autonomic recovery following moderate exercise.", "results_summary": "The study found that avocado pulp intake influenced cardiovascular and autonomic recovery post-exercise, though specific outcomes were not detailed in the abstract. The crossover, randomized design suggests measurable effects compared to placebo.", "population_specificity": "16 healthy female adults", "effective_dosage": "600 mg avocado pulp in capsule (single dose)", "study_duration": "Acute (single administration)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:38.427382+00:00"}
{"study_id": 112182, "supplement_id": 901, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of a new phytotherapeutic combination containing avocado and soya oil for treating lower urinary tract symptoms (LUTS) in patients with benign prostatic hypertrophy (BPH).", "results_summary": "The study found that the avocado-containing combination significantly improved quality of life, uroflow, residual urine, and nocturia in BPH patients compared to controls, without significantly affecting PSA or prostate volume. No noteworthy adverse events were reported.", "population_specificity": "Elderly male patients with BPH-induced LUTS who were candidates for surgery.", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:39.473876+00:00"}
{"study_id": 3001, "supplement_id": 902, "safety_score": "75", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to assess the safety and tolerability of ayahuasca by analyzing adverse events in randomized, placebo-controlled trials involving healthy and clinical populations.", "results_summary": "The study found no serious adverse events, with common side effects including nausea, vomiting, headaches, and transient cardiovascular changes. The abstract suggests potential antidepressant effects but highlights the need for larger, robust clinical trials.", "population_specificity": "Healthy individuals and clinical populations (n = 108 ayahuasca administrations).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:41.388181+00:00"}
{"study_id": 3002, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to examine ayahuasca's ability to stimulate acute cognitive reappraisal and long-term changes in psychological flexibility and mood, while exploring moderating factors for therapeutic changes.", "results_summary": "Participants reported significant reductions in negative mood and increases in positive mood and psychological flexibility after three months. Acute experiences of reappraisal during the ceremony strongly moderated these improvements, with psychological flexibility mediating the effects on positive mood.", "population_specificity": "261 participants recruited from three Shipibo ayahuasca retreat centers in Central and South America.", "effective_dosage": "Not specified", "study_duration": "Three months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:42.186253+00:00"}
{"study_id": 3003, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether ayahuasca could reduce ethanol self-administration in mice and whether these effects were mediated by 5-HT2A receptors.", "results_summary": "Ayahuasca treatment blocked ethanol self-administration, reducing intake and preference, and these effects were dependent on 5-HT2A receptor activation, as pretreatment with an antagonist (M100907) negated ayahuasca's impact.", "population_specificity": "Male mice with intermittent access to ethanol.", "effective_dosage": "100 mg/kg ayahuasca administered via gavage every 3 days.", "study_duration": "30 days of ethanol access followed by 3 treatment phases (duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:43.940209+00:00"}
{"study_id": 3004, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to identify factors predicting smoking cessation or reduction in individuals who consumed ayahuasca.", "results_summary": "The study found that mystical experience and frequency of ayahuasca intake were protective factors for smoking cessation, while positive mood during the experience was a risk factor. Qualitative analysis identified themes like spiritual experience and increased motivation linked to smoking cessation/reduction.", "population_specificity": "Individuals who reported quitting or reducing smoking after ayahuasca consumption.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:44.689328+00:00"}
{"study_id": 3005, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to assess the potential integration of ayahuasca and DMT with contemporary healthcare and summarize literature on their mechanisms of action and reported phenomenology.", "results_summary": "Ayahuasca compounds bind to multiple receptors and modulate brain activity, with subjective effects linked to changes in brain oscillations. Proposed biological and consciousness models lack sufficient evidence, but ayahuasca and DMT show potential as novel treatments.", "population_specificity": "Not specified (narrative review of existing literature).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:45.264879+00:00"}
{"study_id": 3007, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare and contrast Indigenous, recreational, and modern medical understandings of ayahuasca use, highlighting ontological differences and colonial implications.", "results_summary": "The study found that Indigenous use of ayahuasca focuses on interaction with non-human beings, while modern medical applications emphasize neurochemical processes for psychological and somatic benefits, with an ontological incommensurability between these perspectives.", "population_specificity": "Not specified (abstract discusses broad cultural and medical contexts).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:46.616155+00:00"}
{"study_id": 3006, "supplement_id": 902, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the pharmacological profile of ayahuasca and its effects on ethanol rewarding effects using the conditioned place preference (CPP) paradigm in mice.", "results_summary": "Ayahuasca showed no significant adverse effects on motor activity, coordination, or acute toxicity at elevated oral doses. It inhibited ethanol-induced CPP and induced CPP when administered alone, suggesting potential for treating alcohol use disorders.", "population_specificity": "Mice", "effective_dosage": "13, 130, 1300 mg/kg (i.p.); 65, 130, 1300, 2600 mg/kg (v.o.); 250, 500, 750 mg/kg (v.o. for behavioral tests); 500 mg/kg (v.o. for CPP test)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:47.867070+00:00"}
{"study_id": 3008, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to review the history, pharmacology, clinical trials, and clinical and behavioral markers associated with the antidepressant effects of ayahuasca.", "results_summary": "The study found significant and rapid antidepressant effects from ayahuasca, starting as early as 1 day after intervention, based on evidence from open and randomized placebo-controlled clinical trials. Multivariate measures were used to explore these effects.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:47.917199+00:00"}
{"study_id": 3010, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 65, "study_goal": "The researchers aimed to assess the effects of ayahuasca on personality traits, specifically Openness, in healthy volunteers through two randomized, placebo-controlled trials.", "results_summary": "Ayahuasca produced inconsistent effects on personality, with a significant increase in Openness observed only in one trial (placebo + ayahuasca group). No significant changes were found in other personality domains or in the other trial, possibly due to small sample sizes and baseline differences.", "population_specificity": "Healthy volunteers", "effective_dosage": "Not specified", "study_duration": "Single administration, assessed 21 days post-treatment", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:50.126659+00:00"}
{"study_id": 3009, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to assess the effects of ayahuasca on cognitive and emotional processes like flexible thinking, empathy, and well-being, which are often impaired in stress-related psychopathologies.", "results_summary": "The study found that ayahuasca ingestion was associated with increased cognitive empathy, satisfaction with life, and decentering, along with decreased divergent thinking and trait neuroticism, lasting up to 1 week post-ceremony.", "population_specificity": "Volunteers attending ayahuasca ceremonies (43 at baseline, 20 the morning after, 19 at 1-week follow-up; mixed gender).", "effective_dosage": "Not specified", "study_duration": "Single ingestion", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:50.312218+00:00"}
{"study_id": 3011, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to determine the effects of ayahuasca on self-compassion and self-criticism/self-reassurance in a community sample.", "results_summary": "Ayahuasca significantly improved self-compassion, reduced self-criticism, and increased self-reassurance with medium to large effect sizes. The findings suggest potential therapeutic benefits for well-being and negative affect.", "population_specificity": "45 volunteers (60% women), most with prior ayahuasca experience.", "effective_dosage": "Not specified", "study_duration": "Single session (effects measured \u226424 hours post-ceremony)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:52.475173+00:00"}
{"study_id": 3013, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to assess treatment outcomes and understand the therapeutic mechanisms of an Ayahuasca-assisted, integrative treatment model for addiction rehabilitation.", "results_summary": "The study describes a protocol for evaluating Ayahuasca-assisted addiction treatment but does not report specific results regarding its effects. It focuses on understanding why, how, and for whom the treatment is effective.", "population_specificity": "Individuals undergoing addiction rehabilitation at the Takiwasi Center in the Peruvian Amazon.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:53.501270+00:00"}
{"study_id": 3012, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate associations between ayahuasca consumption in naturalistic settings and current alcohol and other drug use, particularly for individuals with prior substance use disorders.", "results_summary": "The study found that ayahuasca consumption was strongly associated with reduced alcohol and drug use, especially among those with prior substance use disorders, with effects linked to spiritual experiences, self-insights, and church participation.", "population_specificity": "8,629 participants (53% male, average age 40 years) from over 40 countries who consumed ayahuasca in religious, traditional, or non-traditional settings.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:53.711317+00:00"}
{"study_id": 3014, "supplement_id": 902, "safety_score": "40", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to review the pharmacology, potential benefits, and risks of ayahuasca, focusing on its traditional use, psychotherapeutic potential, and safety concerns.", "results_summary": "The study highlights ayahuasca's spiritual and psychotherapeutic benefits but notes significant risks, including psychotic episodes and serotonin syndrome, due to poor quality control and unpredictable effects. Healthcare providers need to understand its pharmacology and potential interactions for safe management.", "population_specificity": "Not specified (general discussion, not a clinical study).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "Potential drug interactions with serotonergic agents, risk of serotonin syndrome.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:55.978033+00:00"}
{"study_id": 3015, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess associations between ceremonial practices, support methods, motivations for ayahuasca use, and mental health/wellbeing outcomes.", "results_summary": "The study found significant associations between ceremonial practices, additional supports, and improved mental health outcomes, including reduced psychological distress and enhanced wellbeing. Regression models and GSEM confirmed these relationships, suggesting therapeutic benefits in naturalistic settings.", "population_specificity": "Ayahuasca drinkers from over 40 countries (n = 6,877), including those with prior clinically diagnosed anxiety or depression (n = 1,276).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:56.737215+00:00"}
{"study_id": 3016, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to update a previous systematic review on the therapeutic effects of ayahuasca and its alkaloids in treating Substance Use Disorders (SUDs).", "results_summary": "The study found that ayahuasca and its alkaloids reduced drug use, anxiety, and depression while improving quality of life and well-being in both preclinical and observational studies. However, limitations include lack of causality inference in observational studies and dose standardization issues.", "population_specificity": "Healthy ritual ayahuasca users and patients with SUDs.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:56.955414+00:00"}
{"study_id": 3017, "supplement_id": 902, "safety_score": "30", "efficacy_score": null, "quality_score": 25, "study_goal": "The researchers aimed to highlight cases of psychosis induced by ayahuasca consumption, focusing on a rare adverse event.", "results_summary": "The study described a case of a 26-year-old man who developed psychosis after consuming ayahuasca for the first time, requiring hospitalization and antipsychotic treatment. He responded well to treatment and was discharged with outpatient follow-up.", "population_specificity": "26-year-old male with no prior history of psychosis.", "effective_dosage": "Not specified", "study_duration": "Single use (during a ritual ceremony)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:57.906266+00:00"}
{"study_id": 3019, "supplement_id": 902, "safety_score": "30", "efficacy_score": null, "quality_score": 40, "study_goal": "The researchers aimed to highlight the risks of ayahuasca-induced psychosis and the need for better understanding and regulation of its use.", "results_summary": "The study reported a case of ayahuasca-induced psychosis successfully treated with antipsychotic medication, emphasizing the need for awareness of potential risks and further research.", "population_specificity": "A single patient who experienced a psychotic episode after ayahuasca consumption.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:59.701890+00:00"}
{"study_id": 3020, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore how ritual ayahuasca use during treatment for severe physical illnesses (SPI) influences patients' understanding and relationship with their illness.", "results_summary": "Ayahuasca facilitated illness acceptance through psychological mechanisms like introspection, emotional processing, and illness resignification, leading to perspective changes and a more balanced relationship with illness and treatment.", "population_specificity": "14 individuals consuming ayahuasca ritualistically during treatment for severe physical illnesses (SPI).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:02.632315+00:00"}
{"study_id": 3021, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 65, "study_goal": "The researchers aimed to examine the acute and post-acute effects of ayahuasca on suicidality among individuals with major depressive disorder (MDD).", "results_summary": "The study found significant acute and post-acute decreases in suicidality following ayahuasca administration, with large effect sizes (Hedges' g\u2009=\u20091.31-1.75) and the largest reduction observed 21 days post-intervention.", "population_specificity": "Individuals with recurrent MDD (N\u2009=\u200917, with suicidality at baseline n\u2009=\u200915).", "effective_dosage": "Single dose (specific amount not mentioned).", "study_duration": "Acute effects assessed up to 180 minutes post-administration; post-acute effects tracked for 21 days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:04.745286+00:00"}
{"study_id": 3023, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether DMT, a component of ayahuasca, promotes neurogenesis in the hippocampus and improves memory performance.", "results_summary": "DMT administration activated the subgranular zone of the hippocampus, increased neuron production, and improved memory performance in mice. The neurogenic effect appeared to involve sigma-1 receptor activation, as an S1R antagonist blocked it.", "population_specificity": "Mice (animal study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:04.878354+00:00"}
{"study_id": 3025, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the impact of integrating ayahuasca and traditional Amazonian medicine with psychotherapy on depression and anxiety in an inpatient addiction treatment program.", "results_summary": "Patients showed significant reductions in anxiety and depression scores, along with improved quality of life and spirituality post-treatment. These improvements correlated with reduced anxiety and depression.", "population_specificity": "Male patients (N = 31) in an inpatient addiction treatment program.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:05.593097+00:00"}
{"study_id": 3024, "supplement_id": 902, "safety_score": "65", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to explore the complex action profile, potential benefits, and risks of ayahuasca, including its use in treating drug-resistant depression and addictions.", "results_summary": "The study found promising anti-anxiety and antidepressant effects of ayahuasca, with some results comparable to ketamine. However, it also highlighted risks of interactions and adverse effects due to variability in herbal mixtures.", "population_specificity": "Indigenous people of South America and, more recently, populations in Europe, Asia, Africa, Australia, Canada, and the United States.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Strong and short-acting MAOI-A inhibitors (beta-carboline alkaloids) may interact with other substances.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:06.341285+00:00"}
{"study_id": 3022, "supplement_id": 902, "safety_score": "75", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to review the toxicokinetics, toxicodynamics, therapeutic potential, and forensic aspects of ayahuasca and its alkaloids, particularly focusing on psychological, physiological, and toxic effects.", "results_summary": "The study found that ayahuasca's psychoactive effects are primarily due to DMT activation of 5-HT2A receptors, with harmala alkaloids preventing DMT degradation. Mild to rarely severe psychedelic effects were reported, but abuse did not lead to dependence or tolerance. Potential therapeutic benefits were noted for depression, anxiety, and substance abuse disorders.", "population_specificity": "Not specified (general review, not a clinical trial).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:06.475443+00:00"}
{"study_id": 3026, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of ayahuasca on the rewarding properties of methylphenidate and its potential to block reinstatement of drug-seeking behavior in mice.", "results_summary": "Ayahuasca induced conditioned place preference (CPP) in mice but had limited effects on Fos expression, while methylphenidate altered Fos expression in multiple brain regions. Ayahuasca treatment blocked the reinstatement of methylphenidate-induced CPP and restored normal brain function in areas linked to drug-seeking behavior.", "population_specificity": "Mice", "effective_dosage": "100 mg/kg, orally (ayahuasca); 10 mg/kg, i.p. (methylphenidate)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:08.945212+00:00"}
{"study_id": 3018, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine whether mental health improvements in ayahuasca ceremonies were due to pharmacological effects of ayahuasca or non-pharmacological factors like set and setting.", "results_summary": "The study found reductions in depression, anxiety, and stress symptoms in both ayahuasca and placebo groups, suggesting non-pharmacological factors play a role. However, ayahuasca specifically increased emotional empathy to negative stimuli, indicating pharmacological effects.", "population_specificity": "30 experienced participants of ayahuasca retreats in the Netherlands, Spain, and Germany.", "effective_dosage": "Not specified", "study_duration": "Single session (pre- and post-ceremony assessments)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:11.092815+00:00"}
{"study_id": 3027, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of ayahuasca on inflammatory biomarkers (C-reactive protein and interleukin 6) and their correlation with serum cortisol and brain-derived neurotrophic factor levels in treatment-resistant depression patients and healthy controls.", "results_summary": "Ayahuasca significantly reduced C-reactive protein levels in both patients and controls, with a correlation between larger reductions in C-reactive protein and lower depressive symptoms in patients. No significant effects were found for interleukin 6 or brain-derived neurotrophic factor.", "population_specificity": "Treatment-resistant depression patients (n = 28) and healthy controls (n = 45).", "effective_dosage": "Not specified", "study_duration": "48 hours post-ingestion", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:11.489680+00:00"}
{"study_id": 3028, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to assess the stability of ayahuasca's main alkaloids (DMT, HRM, THH, HRL) under different storage conditions to ensure accurate quantification before administration in studies.", "results_summary": "DMT concentration remained stable in all tested conditions, while harmala alkaloids (THH, HRL, HRM) showed significant variations under long-term and high-temperature storage, including degradation and concentration increases. The study highlights the need for pre-administration quantification due to these stability issues.", "population_specificity": "Not applicable (laboratory study on ayahuasca samples)", "effective_dosage": "Not specified", "study_duration": "Variable (1 year refrigeration, 7 days at 37\u00b0C, 3 freeze-thaw cycles)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:14.020009+00:00"}
{"study_id": 3030, "supplement_id": 902, "safety_score": "80", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate and compare the potential therapeutic benefits versus health risks of ayahuasca intake, focusing on its application in psychedelic psychiatry.", "results_summary": "Ayahuasca may be beneficial as an antidepressant, emotional regulator, anxiolytic, and antiaddictive drug, with fast-acting and enduring clinical effects. It appears safe and well-tolerated, with nausea and emesis as transient side effects, but caution is advised for bipolar or psychotic patients due to increased risks.", "population_specificity": "Healthy volunteers and clinical samples (including psychiatric patients).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:14.496405+00:00"}
{"study_id": 3031, "supplement_id": 902, "safety_score": "85", "efficacy_score": 78, "quality_score": 82, "study_goal": "The researchers aimed to evaluate the neuroprotective potential of Ayahuasca, its plant extracts, fractions, and main alkaloids in an in vitro Parkinson's disease model.", "results_summary": "The study found that Ayahuasca and its components did not cause cytotoxicity and demonstrated neuroprotective effects, particularly hydroalcoholic fractions, which enhanced cell viability and prevented neuronal damage against 6-OHDA-induced toxicity.", "population_specificity": "SH-SY5Y neuroblastoma cells (in vitro model)", "effective_dosage": "Not specified", "study_duration": "48 hours (T1) and 72 hours (T2)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:14.558399+00:00"}
{"study_id": 3029, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to assess the impact of ayahuasca on personality traits in former substance users, particularly focusing on Novelty Seeking, Self-Transcendence, and other related traits.", "results_summary": "The ayahuasca group showed statistically significant increases in Novelty Seeking, Self-Transcendence, Attachment, Impulsivity, Compassion, and Spiritual Acceptance compared to controls. Recovery appeared linked more to enhanced character dimensions (e.g., Self-Transcendence, Cooperativeness) than reduced impulsivity, with qualitative reports highlighting the importance of ritual experiences for personal and social reconstruction.", "population_specificity": "Former substance users from Catalonia and surrounding areas.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:14.573290+00:00"}
{"study_id": 3032, "supplement_id": 902, "safety_score": "85", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential toxic effects of chronic ayahuasca exposure in rats and assess its impact on monoamine levels, metabolites, and BDNF in the brain.", "results_summary": "Ayahuasca was found to be safe in rats, with no significant adverse clinical, hematological, or macroscopic effects. It increased serotonin levels in females, elevated dopamine turnover, and raised BDNF levels in the hippocampus, particularly at higher doses.", "population_specificity": "Female and male rats (7 to 10 animals per group).", "effective_dosage": "0.5X, 1X, and 2X the ritualistic dose (exact human equivalent not specified).", "study_duration": "28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:16.362120+00:00"}
{"study_id": 3033, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to examine the therapeutic potential of ayahuasca in reducing grief severity and explore the roles of experiential avoidance and decentering as mechanisms of change.", "results_summary": "The study found significant reductions in grief severity at all follow-up time points, with strong effect sizes (Cohen's d ranging from 0.84 to 1.39). Experiential avoidance and decentering were identified as psychological processes mediating the improvement in grief symptoms.", "population_specificity": "Bereaved individuals who attended an ayahuasca retreat in Peru.", "effective_dosage": "Not specified", "study_duration": "Single intervention with follow-ups at 15 days, 3 months, 6 months, and 12 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:18.286732+00:00"}
{"study_id": 3034, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 30, "study_goal": "The researchers aimed to describe a participant's experience in a traditional ayahuasca ceremony and assess its immediate and long-term psychological effects.", "results_summary": "The study reported on the participant's experience during the ceremony and noted both immediate and long-term psychological effects, though specific outcomes were not detailed in the abstract.", "population_specificity": "25-year-old male participating in a traditional Costa Rican ayahuasca ceremony.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:18.430905+00:00"}
{"study_id": 3035, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether ayahuasca could reduce suicidality in individuals with treatment-resistant depression.", "results_summary": "The study found medium between-group effect sizes and large within-group effect sizes for decreases in suicidality, with the intervention trending toward significance (p = 0.088). Ayahuasca showed potential as an intervention for suicidality, though further research is needed.", "population_specificity": "Individuals with treatment-resistant depression (n = 29, ayahuasca group n = 14, placebo group n = 15).", "effective_dosage": "One dose of ayahuasca (specific amount not detailed in abstract).", "study_duration": "Effects were assessed at 1 day, 2 days, and 7 days post-intervention.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:20.619945+00:00"}
{"study_id": 3037, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to qualitatively explore the impact of ayahuasca-assisted therapy on addiction and substance use-related outcomes and understand participants' lived experiences.", "results_summary": "Participants reported reduced substance use and cravings, with eight achieving complete cessation of at least one substance. Increased connectedness with self, others, and nature/spirit was linked to these improvements.", "population_specificity": "11 adult Indigenous participants from Canada with problematic substance use.", "effective_dosage": "Not specified", "study_duration": "Retreats conducted between June-September 2011, with follow-up at 6 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:22.551268+00:00"}
{"study_id": 3039, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to explore participant experiences with ceremonial ayahuasca drinking compared to conventional treatment for eating disorders and assess its potential as an adjunctive therapy.", "results_summary": "Participants reported that ayahuasca led to rapid reductions in eating disorder symptoms, facilitated emotional healing, promoted self-love and acceptance, and catalyzed spiritual aspects of recovery. The study suggests ayahuasca may have therapeutic potential for eating disorders.", "population_specificity": "Thirteen individuals previously diagnosed with an eating disorder.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:22.687462+00:00"}
{"study_id": 3038, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate whether ayahuasca modulates serum BDNF levels and its potential link to antidepressant effects in patients with treatment-resistant depression.", "results_summary": "The study found higher BDNF levels in both patients and controls after ayahuasca ingestion compared to placebo, with a significant negative correlation between BDNF levels and depressive symptoms only in ayahuasca-treated patients.", "population_specificity": "Healthy controls (N = 45) and patients with treatment-resistant depression (N = 28).", "effective_dosage": "Single dose (specific amount not provided).", "study_duration": "48-hour follow-up after administration.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:23.217736+00:00"}
{"study_id": 3036, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 65, "study_goal": "The researchers aimed to investigate whether ayahuasca could reduce ethanol intake in rats and its effects on cFos expression in specific brain regions.", "results_summary": "Ayahuasca did not significantly reduce ethanol intake compared to baseline, but it influenced cFos expression in several brain regions, with varying effects depending on dosage. Naltrexone showed a more consistent reduction in ethanol intake than ayahuasca.", "population_specificity": "Wistar rats with intermittent access to ethanol.", "effective_dosage": "0.5x, 1x, and 2x the ritual dose of ayahuasca.", "study_duration": "5 days of treatment after 8 weeks of ethanol access.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:23.646410+00:00"}
{"study_id": 3040, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential antidepressant effects of ayahuasca in a juvenile non-human primate model of depression.", "results_summary": "Ayahuasca restored cortisol levels to baseline within 24 hours, reduced stereotypic behaviors in males, increased feeding, and improved body weight in both sexes, with long-term effects lasting 14 days.", "population_specificity": "Juvenile marmosets (8 males; 7 females) in a depressive state induced by social isolation.", "effective_dosage": "1.67 mL/300 g of body weight, single dose via gavage.", "study_duration": "1 week (acute dose) with follow-up monitoring for tardive effects.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:25.413522+00:00"}
{"study_id": 3041, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to examine the effects of ayahuasca on emotional regulation and mindfulness-related capacities, and secondarily, explore its effects on individuals with borderline personality disorder (BPD) traits.", "results_summary": "Participants showed significant improvements in mindfulness capacities (e.g., observing, non-judging) and emotion regulation (e.g., reduced emotional interference, better control). The BPD-like subgroup also improved in emotion regulation but not mindfulness.", "population_specificity": "45 volunteers, including a subgroup with BPD-like traits (n=12) and a non-BPD-like subgroup (n=33).", "effective_dosage": "Not specified", "study_duration": "Single session, effects measured 24 hours post-consumption.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:27.320407+00:00"}
{"study_id": 3042, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to examine how globalization and legal-political factors influenced the evolution of Takiwasi's hybrid therapeutic practices involving ayahuasca, mestizo shamanism, biomedicine, and Catholicism.", "results_summary": "The study found that Takiwasi's therapeutic approach evolved to incorporate Catholic elements alongside traditional shamanic and biomedical practices, reflecting broader trends in the globalization of ayahuasca use. It highlights the role of religious and medical traditions in legitimizing hybrid ayahuasca practices.", "population_specificity": "National and foreign clients at Takiwasi, a therapeutic community in the Peruvian Amazon, primarily focused on addiction treatment.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:27.713881+00:00"}
{"study_id": 3043, "supplement_id": 902, "safety_score": "40", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of acute and chronic Ayahuasca exposure on cognitive ability and locomotor function in zebrafish using a one-trial learning task.", "results_summary": "Acute Ayahuasca exposure did not affect cognitive performance, but higher concentrations impaired locomotion. Chronic exposure (13 days) impaired discriminative performance and caused locomotor alterations in zebrafish.", "population_specificity": "Adult zebrafish (n = 20 per group).", "effective_dosage": "0.1 and 0.5 ml/L concentrations.", "study_duration": "Acute (single exposure) and chronic (13 days).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:28.968557+00:00"}
{"study_id": 3044, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to explore the therapeutic potential of ayahuasca as perceived by users in the Czech Republic, particularly its effects on drug addiction and memory recall.", "results_summary": "The study found that ayahuasca's therapeutic effects are not directly proportional to its intensity of effects, with users reporting broad therapeutic potential, especially for drug addiction, possibly linked to memory recall.", "population_specificity": "46 individuals (23 women, 23 men) who participated in ayahuasca rituals or facilitated sessions in the Czech Republic.", "effective_dosage": "Not specified", "study_duration": "Fieldwork conducted from November 2015 to December 2016 (intervention duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:31.595101+00:00"}
{"study_id": 3046, "supplement_id": 902, "safety_score": "60", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to describe ayahuasca's pharmacology, potential drug interactions, and clinical data for its treatment potential in psychiatric illnesses.", "results_summary": "The study highlights ayahuasca's potential in treating mental illnesses like substance use and depressive disorders but notes serious drug interactions due to its MAOI properties. Clinical data suggests therapeutic benefits but with significant safety considerations.", "population_specificity": "Not specified (general discussion of ayahuasca use in psychiatric treatment).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Serious drug interactions due to MAOI properties (specific medications not listed).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:31.655527+00:00"}
{"study_id": 3047, "supplement_id": 902, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to test the antidepressant effects of ayahuasca in patients with treatment-resistant depression through a controlled trial.", "results_summary": "Ayahuasca showed significant antidepressant effects compared to placebo at all measured time points, with increasing effect sizes from day 1 to day 7. Response and remission rates were notably higher in the ayahuasca group by day 7.", "population_specificity": "29 patients with treatment-resistant depression.", "effective_dosage": "Single dose (specific amount not mentioned).", "study_duration": "Effects assessed up to 7 days post-dosing.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:31.782189+00:00"}
{"study_id": 3045, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the sub-acute and long-term effects of ayahuasca on well-being and cognitive thinking style, and whether these effects depended on the degree of ego dissolution experienced during the ceremony.", "results_summary": "Ayahuasca significantly reduced depression and stress immediately after the ceremony, with effects persisting for 4 weeks. Convergent thinking improved post-ceremony and remained enhanced at follow-up, while satisfaction with life and mindfulness increased temporarily but not significantly at 4 weeks. Changes were correlated with ego dissolution but not prior ayahuasca experience.", "population_specificity": "Ayahuasca ceremony attendants in the Netherlands and Colombia (N=57).", "effective_dosage": "Not specified", "study_duration": "Single ceremony, effects assessed the day after and 4 weeks later.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:32.359119+00:00"}
{"study_id": 3049, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to explore the effects of ayahuasca on plasma and awakening salivary cortisol response in treatment-resistant depression patients and healthy volunteers.", "results_summary": "Ayahuasca normalized blunted awakening salivary cortisol response in treatment-resistant patients to levels similar to healthy controls within 48 hours, with no significant changes in plasma cortisol. The study suggests ayahuasca modulates cortisol levels, potentially aiding depression treatment.", "population_specificity": "Treatment-resistant depression patients (MD) and healthy volunteers (C).", "effective_dosage": "Single dose (specific amount not mentioned).", "study_duration": "48-hour follow-up after dosing.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:35.840567+00:00"}
{"study_id": 3048, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether ayahuasca's therapeutic effects on ethanol abuse depend on DMT or if non-DMT components alone are effective, using a conditioned place preference paradigm in mice.", "results_summary": "An intermediate dose of ayahuasca induced conditioned place preference (CPP) and blocked ethanol-induced CPP, while Bc and Pv extracts alone did not induce CPP but blocked ethanol reward expression when administered post-conditioning. The treatment environment influenced the therapeutic effects of ayahuasca and Bc.", "population_specificity": "Male mice", "effective_dosage": "Ayahuasca (30, 100, 300 mg/kg orally), Bc (132, 440, 1320 mg/kg orally), Pv (3.75, 12.5, 37.5 mg/kg i.p.), ethanol (1.8 g/kg i.p.)", "study_duration": "8 conditioning sessions for initial testing, 6 days for post-conditioning treatment", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:36.116596+00:00"}
{"study_id": 3050, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the mechanisms by which Ayahuasca might facilitate the retrieval and reprocessing of traumatic memories in PTSD patients, focusing on SIGMAR1 activation and MAOI effects.", "results_summary": "The study suggests Ayahuasca may enhance synaptic plasticity, neurogenesis, and dopaminergic neurotransmission, potentially aiding in memory reconsolidation and fear extinction. It hypothesizes that Ayahuasca's effects on SIGMAR1 and MAOIs could help heal traumatic memories in PTSD.", "population_specificity": "PTSD patients (pre-clinical models mentioned, but human implications are discussed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:36.294698+00:00"}
{"study_id": 3051, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 68, "study_goal": "The researchers aimed to explore the link between ayahuasca use and psychological processes like Decentering, Values, and Self, comparing experienced users with non-users.", "results_summary": "Ayahuasca users scored higher in Decentering and Positive self compared to non-users, but no differences were found in other psychological variables. More experienced users (over 15 occasions) showed higher Decentering scores than less experienced ones.", "population_specificity": "Subjects without ayahuasca experience (n=41) and subjects with ayahuasca experience (n=81).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:37.536114+00:00"}
{"study_id": 3052, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to understand how crack cocaine users recover from addiction by consuming ayahuasca tea in a religious context.", "results_summary": "Participants reported that ayahuasca helped them access a consciousness dimension to address traumas, reduce crack cocaine use, and improve emotional and social well-being through religious ceremonies and community support. The positive experience was incorporated into daily routines for most participants.", "population_specificity": "40 crack cocaine users in Brazil.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:39.191907+00:00"}
{"study_id": 3054, "supplement_id": 902, "safety_score": "75", "efficacy_score": 80, "quality_score": 65, "study_goal": "The researchers aimed to explore the potential therapeutic value of ayahuasca for individuals with eating disorders, including the impact of the preparatory diet and the ayahuasca purge.", "results_summary": "The study found that ceremonial ayahuasca drinking was associated with reduced or ceased eating disorder symptoms, improved body perception, and mental health benefits, with no triggering effects from the purge. The ceremonial setting and after-care were highlighted as important factors.", "population_specificity": "Sixteen individuals previously diagnosed with an eating disorder.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:39.924299+00:00"}
{"study_id": 3053, "supplement_id": 902, "safety_score": "20", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the developmental toxicity of Ayahuasca in pregnant rats and assess potential risks to the conceptus.", "results_summary": "Ayahuasca caused dose-dependent mortality, kidney injury, neuronal loss, delayed intrauterine growth, embryo deaths, and increased fetal anomalies in rats. Non-lethal doses still enhanced embryolethality and fetal anomalies.", "population_specificity": "Pregnant rats (gestation days 6-20).", "effective_dosage": "1X to 8X the average human ritual dose (exact amounts not specified).", "study_duration": "15 days (gestation days 6-20).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:40.400639+00:00"}
{"study_id": 3055, "supplement_id": 902, "safety_score": "80", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to determine whether chronic ayahuasca exposure during aging affects spatial reference and habituation memories in mice.", "results_summary": "Chronic ayahuasca exposure did not alter age-related impairments in spatial reference memory evocation, habituation, or locomotor activity, nor did it affect anxiety parameters. The study found no significant impact of ayahuasca on memory or behavior in aging mice.", "population_specificity": "Male c57bl/6 mice (6 months old at study start).", "effective_dosage": "1.5 mL/kg, orally, twice a week.", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:41.565500+00:00"}
{"study_id": 3056, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the potential effects of ayahuasca on grief by comparing its outcomes with peer-support groups.", "results_summary": "The ayahuasca group showed lower grief levels on the Present Feelings Scale and reported emotional release, biographical memories, and experiences of contact with the deceased. Some psychological and interpersonal benefits were identified.", "population_specificity": "30 individuals who had taken ayahuasca compared to 30 who attended peer-support groups, all experiencing grief.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:44.319002+00:00"}
{"study_id": 3058, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 65, "study_goal": "The researchers aimed to understand how ayahuasca's ritual use supports addiction recovery by examining its somatic, symbolic, and collective dimensions.", "results_summary": "Ayahuasca's efficacy in treating addiction involves layered somatic, symbolic, and collective effects, enhanced by ritual context. The study highlights the therapeutic role of communal caregiving and feeling part of a community in addiction recovery.", "population_specificity": "Participants with histories of substance misuse in ayahuasca communities.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:44.529849+00:00"}
{"study_id": 3057, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the post-acute neurometabolic and connectivity changes induced by ayahuasca and their association with mindfulness measures in healthy volunteers.", "results_summary": "The study found post-acute reductions in glutamate+glutamine, creatine, and N-acetylaspartate+N-acetylaspartylglutamate in the posterior cingulate cortex, along with increased connectivity between the posterior cingulate cortex and anterior cingulate cortex, and between the anterior cingulate cortex and limbic structures. These changes correlated with improved mindfulness and self-compassion scores.", "population_specificity": "16 healthy volunteers", "effective_dosage": "Single dose (amount not specified)", "study_duration": "Post-acute effects measured (specific duration not detailed)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:45.279373+00:00"}
{"study_id": 3059, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to assess the potential effects of ayahuasca on creative divergent and convergent thinking.", "results_summary": "Ayahuasca intake significantly modified divergent and convergent thinking, increasing divergent thinking while decreasing convergent thinking, as measured by the PCT, but showed no significant effects on the PLMT.", "population_specificity": "Participants from two spiritual ayahuasca workshops (n=26).", "effective_dosage": "Not specified", "study_duration": "Acute effects (single session)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:46.383821+00:00"}
{"study_id": 3060, "supplement_id": 902, "safety_score": "80", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to assess the therapeutic potential of ayahuasca, psilocybin, and LSD for mood and anxiety disorders and drug dependence through a systematic review of clinical trials.", "results_summary": "The review found preliminary evidence of beneficial effects for treatment-resistant depression, anxiety, depression in life-threatening diseases, and tobacco and alcohol dependence, with all drugs being well tolerated. However, studies had small sample sizes and limited methodological rigor.", "population_specificity": "Treatment-resistant patients with mood and anxiety disorders or drug dependence.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:47.094388+00:00"}
{"study_id": 57915, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The abstract does not specify a study goal but mentions Ayahuasca's traditional use for therapeutic and ritual purposes.", "results_summary": "The abstract does not provide study results, only background information on Ayahuasca's composition and traditional use.", "population_specificity": "Indigenous groups from Northwestern Amazonian countries (Brazil, Peru, Colombia, Ecuador).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:47.967601+00:00"}
{"study_id": 57913, "supplement_id": 902, "safety_score": "85", "efficacy_score": 75, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the safety, pharmacokinetics, and subjective effects of a novel pharmaceutical formulation containing DMT and harmine as a potential alternative to traditional ayahuasca.", "results_summary": "The study found that the DMT-harmine formulation produced consistent pharmacokinetic profiles and acute psychological effects resembling ayahuasca, with a duration of 2-3 hours. The formulation was safe and well-tolerated, with no significant adverse events reported.", "population_specificity": "31 healthy male volunteers", "effective_dosage": "100 mg buccal harmine with 100 mg intranasal DMT (administered as 10 mg DMT every 15 minutes)", "study_duration": "Repeated-intermittent dosing scheme (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:48.924538+00:00"}
{"study_id": 57917, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of classic psychedelic drugs, including ayahuasca, on cognitive and emotional empathy.", "results_summary": "The meta-analysis found that classical psychedelics, including ayahuasca, significantly enhanced explicit and implicit emotional empathy but did not affect cognitive empathy.", "population_specificity": "Not specified (meta-analysis of multiple studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:50.951509+00:00"}
{"study_id": 57918, "supplement_id": 902, "safety_score": "75", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to explore the therapeutic potential and Indigenous roots of ayahuasca and other entheogens in managing substance use disorders (SUDs).", "results_summary": "Observational and preliminary clinical studies suggest ayahuasca has therapeutic potential and relative safety in appropriate contexts, particularly when combined with psychotherapeutic interventions. The study highlights the need for culturally attuned therapeutic strategies and further interdisciplinary research.", "population_specificity": "Individuals with substance use disorders (SUDs) and broader mental health contexts.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:52.756563+00:00"}
{"study_id": 57919, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to examine the association between antidepressant efficacy and study designs in psychedelic trials, including Ayahuasca.", "results_summary": "Ayahuasca showed a large effect size in both pre-post (g = 1.88) and non-active-drug-as-placebo (g = 1.60) designs, indicating significant antidepressant effects. The study suggests that antidepressant effects of psychedelics like Ayahuasca may be overestimated in certain study designs.", "population_specificity": "Adult patients with depressive symptoms.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:53.195421+00:00"}
{"study_id": 57921, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 45, "study_goal": "The researchers aimed to assess the therapeutic use of tobacco by Indigenous healers in the Peruvian Amazon, not Ayahuasca.", "results_summary": "The abstract does not provide results related to Ayahuasca, as the study focused on tobacco use by traditional healers.", "population_specificity": "Patients treated by a traditional healer specializing in tobacco in the Peruvian Amazon.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:54.315169+00:00"}
{"study_id": 57922, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of ayahuasca as a fast-acting and long-lasting treatment for treatment-resistant depression (TRD).", "results_summary": "The abstract suggests that ayahuasca, like other serotonergic psychedelics, exhibits a rapid and sustained antidepressant effect beyond its biological presence, indicating involvement of downstream brain mechanisms. Adverse effects and tolerability in the studied dose ranges were generally acceptable.", "population_specificity": "Individuals with treatment-resistant depression (TRD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:55.633826+00:00"}
{"study_id": 57920, "supplement_id": 902, "safety_score": "75", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to explore the pharmacology, effects, safety, and toxicity of ayahuasca, with a focus on its potential non-mental medical applications in anesthesia and clinical practice.", "results_summary": "The study highlights ayahuasca's potential in treating chronic pain, palliative care, and neuroprotection, while also detailing safety protocols and adverse effect management. It emphasizes the role of anesthetists in clinical and experimental research with psychedelics.", "population_specificity": "Patients with multiple comorbidities, functional limitations, and polymedication, as well as participants in neuroimaging studies during psychedelic experiences.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:56.856262+00:00"}
{"study_id": 57923, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to synthesize current knowledge on the pharmacology and neuroscience of DMT, \u03b2-carbolines, and ayahuasca to inform future therapeutic research.", "results_summary": "The study found that ayahuasca, through the synergistic effects of DMT and MAOIs, may promote neuroplasticity and shows promising therapeutic efficacy for neuropsychiatric disorders like depression, addiction, and PTSD. Neuroimaging revealed alterations in brain activity and connectivity during DMT-induced altered states.", "population_specificity": "Not specified (general review of existing research)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "\u03b2-carbolines or synthetic MAO-A inhibitors (MAOIs) increase DMT's bioavailability and duration of action.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:57.897934+00:00"}
{"study_id": 57914, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the quality of reporting on psychological interventions in psychedelic-assisted psychotherapy studies, including those involving ayahuasca.", "results_summary": "The study found that reporting on psychological interventions in ayahuasca research was heterogeneous and often incomplete, limiting replicability and generalizability. MDMA studies provided more procedural details, while ayahuasca studies lacked consistency in intervention descriptions.", "population_specificity": "Patients with mental disorders (specific conditions not detailed in the abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:58.277922+00:00"}
{"study_id": 57924, "supplement_id": 902, "safety_score": "75", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to review emerging evidence on the potential of psychedelics, including ayahuasca, for treating alcohol use disorder (AUD).", "results_summary": "The study found that psychedelics, including ayahuasca, show promise in treating AUD by modulating neuroplasticity, with some participants achieving positive results from a single dose, though effects vary between individuals.", "population_specificity": "Individuals with alcohol use disorder (AUD) or treatment-resistant addiction.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:58.839929+00:00"}
{"study_id": 57926, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the potential role of gut microbiota in mediating the effects of psychedelics, including Ayahuasca, on behavior and mental health.", "results_summary": "The study suggests that gut microbiota may influence the effects of psychedelics and that microbial metabolism could modulate these effects, highlighting the need for future research on microbiome contributions to psychedelic action.", "population_specificity": "Not specified (review article)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:00.457978+00:00"}
{"study_id": 57925, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness and acceptability of psychedelics, including Ayahuasca, versus escitalopram in treating depressive symptoms, while accounting for potential biases in blinding.", "results_summary": "The study did not report specific results for Ayahuasca's efficacy or safety, focusing instead on high-dose psilocybin as the only psychedelic showing a small but significant effect over placebo in antidepressant trials.", "population_specificity": "Adults with depressive symptoms.", "effective_dosage": "Not specified for Ayahuasca.", "study_duration": "Not specified for Ayahuasca.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:00.833692+00:00"}
{"study_id": 57927, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to describe calls to the New South Wales Poisons Information Centre related to exposures to classical psychedelics, including ayahuasca, to assess toxicity and clinical outcomes.", "results_summary": "The study found 4 calls (0.5% of total) related to ayahuasca exposures, with no specific details on adverse effects or outcomes provided for ayahuasca alone. The broader findings indicated co-ingestion with other substances in 33.8% of psychedelic cases and common clinical features like hallucinations, gastrointestinal symptoms, and tachycardia.", "population_specificity": "Cases were predominantly male (77.2%) and aged between 20 and 74 years (65.6%).", "effective_dosage": "Not available", "study_duration": "Retrospective data from January 2014 to December 2022", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:03.730915+00:00"}
{"study_id": 57928, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the methodological challenges, particularly blinding procedures, in randomized controlled trials (RCTs) involving psychedelics like Ayahuasca for psychiatric disorders.", "results_summary": "The study found that traditional placebo administration is insufficient for controlling expectancy effects in psychedelic trials and highlighted the importance of active placebos and limiting personnel unblinding for future research design.", "population_specificity": "Not specified (systematic review of RCTs involving psychedelics for psychiatric disorders)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:04.709006+00:00"}
{"study_id": 57930, "supplement_id": 902, "safety_score": "75", "efficacy_score": 87, "quality_score": 85, "study_goal": "The researchers aimed to systematically review and meta-analyze the effectiveness and safety of ayahuasca (DMT) in treating symptoms of various mental disorders, particularly mood disorders.", "results_summary": "Ayahuasca showed a strong therapeutic effect (Hedges' g = -1.34) for mood disorders, ranking second among the psychedelics studied. Adverse events were generally mild, with headache being the most common, and nearly a third of studies reported no lasting adverse effects.", "population_specificity": "Individuals with mental disorders, including depression, anxiety, and other conditions like substance-use disorders and PTSD.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:05.500721+00:00"}
{"study_id": 57932, "supplement_id": 902, "safety_score": "75", "efficacy_score": null, "quality_score": 80, "study_goal": "The researchers aimed to systematically review adverse events, safety, and toxicity of traditional ayahuasca preparations and its main psychoactive alkaloids, focusing on clinical considerations.", "results_summary": "The study found that ayahuasca and DMT are generally safe, with rare serious adverse effects in healthy populations, though preclinical models indicated potential toxicity at higher doses, particularly with harmala alkaloids. Animal studies showed abortifacient and teratogenic effects at high doses, but these may not extrapolate to therapeutic human use.", "population_specificity": "Preclinical models, clinical trials, and healthy populations in controlled settings.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Potential toxicity may increase with co-administration of certain medications.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:06.548933+00:00"}
{"study_id": 57933, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the potential of psychedelic compounds, including Ayahuasca, for treating PTSD and trauma-related disorders, examining their history, effects, pharmacology, and safety.", "results_summary": "The abstract suggests that initial clinical trials indicate potential value for Ayahuasca in treating PTSD and trauma-related disorders, though detailed results are not provided. The review discusses the psychological and somatic effects, pharmacology, and safety profile of Ayahuasca among other psychedelics.", "population_specificity": "Individuals with PTSD and trauma-related disorders (general review, not a specific study population).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:07.406453+00:00"}
{"study_id": 57935, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the interplay between music and psychedelics, particularly ayahuasca, focusing on its role in therapy and indigenous rituals, as well as its neural and evolutionary connections.", "results_summary": "The abstract highlights the association between music and psychedelics in guiding experiences, discusses their neural overlap, and examines music's role in ayahuasca rituals and Western therapy, but does not provide specific findings on ayahuasca's effects.", "population_specificity": "Not specified (general discussion of ayahuasca use in indigenous and therapeutic contexts)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:08.316674+00:00"}
{"study_id": 57934, "supplement_id": 902, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the safety and tolerability of inhaled DMT (BMND01 candidate) in healthy volunteers.", "results_summary": "Inhaled DMT dose-dependently increased subjective experiences and positive valence, with mild, transient increases in blood pressure and heart rate but no serious adverse events or changes in safety biomarkers. The study suggests inhaled DMT may be a safe and efficient route of administration.", "population_specificity": "27 healthy volunteers", "effective_dosage": "5/20 mg, 7.5/30 mg, 10/40 mg, 12.5/50 mg, or 15/60 mg (two doses per participant)", "study_duration": "Single-ascending, fixed-order dose-response study (acute and post-acute effects assessed)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:08.402974+00:00"}
{"study_id": 57936, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review outcome measures used in studies on classical psychedelics, including ayahuasca, to assess dimensions of the acute subjective psychedelic experience.", "results_summary": "The study identified 17 different rating scales used in 93 trials, with the most utilized being the Five-Dimensional Altered States of Consciousness Questionnaire, visual analog/Likert scales, the Hallucinogen Rating Scale, the States of Consciousness Questionnaire, and the Abnormer Psychischer Zustand. The authors noted considerable variability in instruments and advised developing a core outcome set for psychedelic research.", "population_specificity": "Not specified (general research on classical psychedelics, including ayahuasca)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:09.593892+00:00"}
{"study_id": 57938, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of Ayahuasca and other psychedelics for treating treatment-resistant depression (TRD).", "results_summary": "The abstract suggests that Ayahuasca, along with other psychedelics, shows promise in treating TRD, with potential rapid antidepressant effects, though long-term effects and mechanisms require further study.", "population_specificity": "Adults with treatment-resistant depression (TRD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:10.906301+00:00"}
{"study_id": 57939, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review metabolic and metabolomic studies of Ayahuasca and other psychedelics to understand their biological effects, mechanisms of action, and therapeutic potential.", "results_summary": "The study found that while the main metabolites of Ayahuasca have been robustly established, the metabolic alterations induced by psychedelics require further exploration. Integrating metabolomics and pharmacokinetics may enhance understanding of their therapeutic role.", "population_specificity": "Humans (specific demographics not detailed in the abstract).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:12.092530+00:00"}
{"study_id": 57941, "supplement_id": 902, "safety_score": "65", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to critically discuss the cardiovascular safety of ayahuasca and other psychedelics based on experimental and clinical trial data.", "results_summary": "The study found that psychedelics, including ayahuasca, show relative cardiovascular safety in healthy volunteers but lack sufficient data for patients with cardiovascular disease. Experimental studies provided inconsistent information on cardiovascular effects and toxicity.", "population_specificity": "Healthy volunteers and patients with cardiovascular disease (latter data insufficient).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:14.078054+00:00"}
{"study_id": 57940, "supplement_id": 902, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to evaluate a novel method of continuous intravenous DMT administration to extend the psychedelic experience while maintaining psychological and physiological safety.", "results_summary": "The study found that continuous IV DMT administration effectively extended the psychedelic experience in a stable and tolerable manner, with low anxiety ratings and habituated heart rate. Plasma DMT concentrations increased steadily, while psychological effects plateaued, suggesting acute tolerance development.", "population_specificity": "Eleven healthy volunteers (seven male, four female, mean age 37.09 \u00b1 8.93 years).", "effective_dosage": "Four dose regimens consisting of a bolus loading dose and slow-rate infusion (specific amounts not detailed in abstract).", "study_duration": "30 minutes of active infusion.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:14.326971+00:00"}
{"study_id": 57942, "supplement_id": 902, "safety_score": "65", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety and efficacy of ayahuasca and other non-psilocybin serotonergic psychedelics in treating mental and substance use disorders.", "results_summary": "The study found that ayahuasca was associated with benefits such as improved mood, reduced anxiety, enhanced insight, and decreased substance use, but also reported adverse effects including psychological, neurological, and gastrointestinal symptoms. Serious adverse events were not specifically linked to ayahuasca in this review.", "population_specificity": "Individuals with mental and substance use disorders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:15.242534+00:00"}
{"study_id": 57944, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to review preliminary data on the efficacy and potential therapeutic mechanisms of psychedelic-assisted therapy, including ayahuasca, in treating anorexia nervosa, bulimia nervosa, and binge eating disorder.", "results_summary": "Preliminary evidence suggests psychedelic-assisted therapy, including ayahuasca, may be effective for anorexia nervosa and bulimia nervosa, with potential benefits in improving body image beliefs, reward processing, cognitive flexibility, and trauma processing. Limited data was available for binge eating disorder.", "population_specificity": "Individuals with anorexia nervosa, bulimia nervosa, and binge eating disorder.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:16.900961+00:00"}
{"study_id": 57946, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to explore the therapeutic potential of Ayahuasca in treatment-resistant depression (TRD) and assess its early promising results.", "results_summary": "Early studies show promising results for Ayahuasca in TRD, but evidence remains limited. Future research is needed to understand its neurobiological effects and clinical applications.", "population_specificity": "Individuals with treatment-resistant depression (TRD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:16.974327+00:00"}
{"study_id": 57943, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 35, "study_goal": "The researchers aimed to evaluate the risk of bias and methodological challenges in clinical trials involving classical psychedelics, including ayahuasca.", "results_summary": "The study found that trials on classical psychedelics, including ayahuasca, had small samples, high dropout rates, unsuccessful or unreported blinding, and were predominantly rated as high risk of bias. Few trials published protocols or evaluated psychotherapy fidelity.", "population_specificity": "Predominantly white and highly educated individuals.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:17.339403+00:00"}
{"study_id": 57947, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to propose evidence-informed guidelines for setting personal possession limits of psychedelic substances, including Ayahuasca, based on clinical and naturalistic dose data.", "results_summary": "The study provided a table of typical moderate-high doses for seven psychedelics, including Ayahuasca, to inform policy decisions on allowable possession limits, advocating for consistency with clinical and naturalistic use data.", "population_specificity": "Not specified (general policy discussion)", "effective_dosage": "Not specified (moderate-high doses referenced but not quantified)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:19.329254+00:00"}
{"study_id": 57949, "supplement_id": 902, "safety_score": "65", "efficacy_score": 80, "quality_score": 75, "study_goal": "To assess the role of psychedelics, including Ayahuasca, in treating anxiety and depression in cancer patients.", "results_summary": "The study found significant reductions in anxiety and depression scores in psychedelic-treated patients compared to placebo, with benefits potentially lasting 6 to 12 months. However, the studies were small and had methodological limitations, including increases in blood pressure and heart rate.", "population_specificity": "Patients with cancer experiencing anxiety or depression.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:19.511751+00:00"}
{"study_id": 57950, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to categorize and analyze state and local psychedelic laws, including those related to Ayahuasca, into five general types.", "results_summary": "The study identified five categories of psychedelic laws (decriminalization, supported adult use, medical use, clinical research, and policy analysis) and noted that some jurisdictions create hybrid laws blending multiple categories. It also highlighted that government agencies can shift laws between categories during rulemaking.", "population_specificity": "Not specified (focus on legal frameworks, not human subjects)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:22.243731+00:00"}
{"study_id": 57954, "supplement_id": 902, "safety_score": "75", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to critically appraise current evidence for the antidepressant effects of ayahuasca in treatment-resistant depression and identify methodological limitations in clinical trials.", "results_summary": "Two studies showed preliminary positive effects of single-dose ayahuasca for treatment-resistant depression, with adverse events reported as mild and transient. However, small homogenous samples and other limitations reduce the robustness of these findings.", "population_specificity": "Patients with treatment-resistant depression.", "effective_dosage": "Single-dose (specific amount not mentioned).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:22.820785+00:00"}
{"study_id": 57951, "supplement_id": 902, "safety_score": "75", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to provide a comprehensive overview of ayahuasca's therapeutic effects across various clinical conditions, including psychiatric, neurological, and physical illnesses, based on human and preclinical studies.", "results_summary": "The study found consistent evidence supporting ayahuasca's therapeutic benefits for depression and substance use disorders, with emerging but less robust evidence for conditions like anxiety, grief, eating disorders, PTSD, and neurodegenerative diseases. Preliminary data on long-term ayahuasca users suggested potential health benefits without detrimental effects.", "population_specificity": "Human (clinical, cross-sectional, observational, qualitative) and preclinical (animal and in vitro) studies.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:23.060561+00:00"}
{"study_id": 57957, "supplement_id": 902, "safety_score": "65", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the antidepressant effects of ayahuasca in treatment-resistant depression.", "results_summary": "Two pilot studies showed preliminary positive effects of single-dose ayahuasca for treatment-resistant depression, but small sample sizes and functional unblinding were major limitations. Adverse events were generally transient, including psychological and physical effects.", "population_specificity": "Individuals with treatment-resistant depression.", "effective_dosage": "Single-dose (specific amount not mentioned).", "study_duration": "Single administration.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:24.414693+00:00"}
{"study_id": 57956, "supplement_id": 902, "safety_score": "75", "efficacy_score": null, "quality_score": 80, "study_goal": "The researchers aimed to systematically review the presence of adverse events (AEs) during and after administration of serotonergic psychedelics, including ayahuasca, in clinical studies.", "results_summary": "The study found that ayahuasca treatments were generally well tolerated, with nausea, headaches, and anxiety commonly reported as acute adverse events. No serious adverse events requiring medical intervention were reported for ayahuasca.", "population_specificity": "598 unique patients across 44 studies, including those treated with MDMA and serotonergic psychedelics (psilocybin, LSD, and ayahuasca).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:25.350913+00:00"}
{"study_id": 57955, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to examine the effects of psychedelics, including ayahuasca, on neuroplasticity and their potential long-term clinical benefits for treating depression, anxiety, and addiction.", "results_summary": "The study found that psychedelics like ayahuasca promote neuroplasticity, including dendritogenesis, synaptogenesis, and neurogenesis, with long-lasting clinical improvements. The effects were observed in brain regions such as the prefrontal cortex and hippocampus, but the duration and dosage requirements for these effects were not conclusively determined.", "population_specificity": "Not specified (general discussion of psychedelics' effects, not a specific clinical trial).", "effective_dosage": "Not specified (mentions hallucinogenic doses vs. microdoses but no exact amounts).", "study_duration": "Not specified (mentions long-term effects lasting months or years but no intervention duration).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:26.665878+00:00"}
{"study_id": 57958, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the antidepressant effects of ayahuasca on treatment-resistant depression (TRD) and its potential association with changes in inflammatory and neurotrophic biomarkers.", "results_summary": "The study found that results for all biomarkers assessed were contradictory and inconclusive, highlighting the need for larger, more robust trials to clarify ayahuasca's antidepressant effects.", "population_specificity": "Individuals with treatment-resistant depression (TRD).", "effective_dosage": "1 mL/kg (oral administration).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:26.800849+00:00"}
{"study_id": 57959, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize current knowledge on the long-term effects of psychedelics, including Ayahuasca, on neural plasticity and mental health outcomes.", "results_summary": "The study highlights that psychedelics, including Ayahuasca, produce long-lasting effects on personality (e.g., increased openness) and depressive symptoms, supported by behavioral, biochemical, neuroimaging, and electrophysiological data. These effects are attributed to neural plasticity.", "population_specificity": "Healthy individuals and those with neuropsychiatric disorders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:27.224229+00:00"}
{"study_id": 57963, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to provide a unifying account of unimodal and multimodal erroneous percepts, including hallucinations, based on circular inference, without specific focus on Ayahuasca.", "results_summary": "The study proposed a model where amplification of top-down predictions leads to crossmodal percepts and illusions, while amplification of bottom-up information results in unimodal hallucinations and reduced illusion vulnerability. It delineated a canonical microcircuit involving layer-specific inhibition to control information propagation.", "population_specificity": "Not specified (theoretical/model-based study)", "effective_dosage": "Not available", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:30.834447+00:00"}
{"study_id": 57962, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the ethical challenges and potential risks associated with the attribution of truth and meaningfulness in psychedelic experiences, particularly with Ayahuasca, in therapeutic, neo-shamanic, and research contexts.", "results_summary": "The study highlights that psychedelics like Ayahuasca can enhance the attribution of truth and meaningfulness to experiences, which may lead to therapeutic benefits but also risks such as false memory syndrome. It proposes an ethical framework to address these challenges.", "population_specificity": "Not specified (general discussion on psychedelic use in therapeutic, neo-shamanic, and research contexts).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:31.356402+00:00"}
{"study_id": 57966, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the rapid antidepressant effects of Ayahuasca compared to placebo in a clinical trial setting.", "results_summary": "Ayahuasca demonstrated a greater response rate than placebo at week one, indicating rapid antidepressant effects. The study identified it as one of several compounds with promising phase II trial results for depression treatment.", "population_specificity": "Patients with major depressive disorder or treatment-resistant depression (specific demographics not detailed in the abstract).", "effective_dosage": "Not specified", "study_duration": "Effects measured at one week (intervention duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:33.059666+00:00"}
{"study_id": 57965, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to assess the long-term effects of ayahuasca on depressive symptomatology in clinically depressed patients and explore correlations with altered states of consciousness and ego dissolution.", "results_summary": "Ayahuasca significantly reduced depressive symptoms (BDI scores) from baseline to 1-day, 1-month, and 1-year follow-ups, with remission rates of 60-71%. Improvements in secondary mental health measures, mindfulness, and life satisfaction persisted up to 1 year, correlating with ego dissolution and oceanic boundlessness during the ceremony.", "population_specificity": "20 clinically depressed patients (BDI > 13).", "effective_dosage": "Not specified.", "study_duration": "Single ceremony, with follow-ups at 1 day, 1 month, and 1 year.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:34.058383+00:00"}
{"study_id": 57967, "supplement_id": 902, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "To assess potential risks and benefits of psychedelic drugs, including ayahuasca, as therapeutics and identify future research directions.", "results_summary": "The study found that psychedelic-assisted psychotherapy, including ayahuasca, can offer significant and sustained alleviation of psychiatric symptoms with no serious adverse events reported. Limitations include small sample sizes and limited follow-up.", "population_specificity": "Psychiatric conditions (specifics not detailed in abstract).", "effective_dosage": "Not specified in abstract.", "study_duration": "Not specified in abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:34.651405+00:00"}
{"study_id": 57968, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of ayahuasca as a treatment for depression, particularly in the context of emerging psychedelic-based pharmacotherapies.", "results_summary": "The study suggests that ayahuasca shows promise as a potential treatment for depression, alongside other psychedelics like psilocybin and MDMA, though definitive Phase III trials are lacking. Current evidence is encouraging but limited by small sample sizes and challenges in blinding.", "population_specificity": "Individuals with mood disorders, including treatment-resistant depression.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:34.912213+00:00"}
{"study_id": 57969, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the potential of psychedelics, including Ayahuasca, to treat neuropsychiatric and neurodegenerative disorders by examining their impact on neurotrophic factors, neuronal growth, and immune modulation.", "results_summary": "The study suggests psychedelics may rescue cortical atrophy and show broad therapeutic potential for brain disorders, though their application to neurodegenerative diseases remains unexplored. The primary target, 5-HT receptors, indicates a plausible mechanism for these effects.", "population_specificity": "Not specified (general discussion of psychedelics' potential)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:35.454630+00:00"}
{"study_id": 57970, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers sought to determine the extent of NIH funding for clinical trials involving psychedelic-assisted therapies, including Ayahuasca, from 2006-2020.", "results_summary": "The study found zero NIH grants directly funding psychedelic-assisted therapy clinical trials, including those involving Ayahuasca, during the study period. The lack of funding contrasts with governmental support in other countries.", "population_specificity": "Not specified (analysis focused on NIH funding data).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:38.648225+00:00"}
{"study_id": 57961, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the potential benefits of psychedelics, including ayahuasca, in combination with psychotherapy for managing PTSD, particularly focusing on fear memory disruption.", "results_summary": "The abstract suggests that ayahuasca, along with other psychedelics, shows early evidence of beneficial effects for PTSD treatment by potentially reducing barriers to therapy and modifying trauma-related memories. However, large-scale clinical trials are needed for conclusive evidence.", "population_specificity": "Individuals with PTSD (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:39.837646+00:00"}
{"study_id": 57971, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the potential of Ayahuasca as a novel treatment for major depressive disorder (MDD) and treatment-resistant depression (TRD), focusing on its efficacy beyond traditional monoamine pathways.", "results_summary": "The abstract mentions preliminary positive clinical trial results with Ayahuasca, suggesting it may be effective for MDD and TRD, though specific outcomes are not detailed. The study highlights Ayahuasca as part of a broader exploration of psychedelic drugs for depression.", "population_specificity": "Adult patients with major depressive disorder (MDD) and treatment-resistant depression (TRD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:39.952533+00:00"}
{"study_id": 57972, "supplement_id": 902, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine how Ayahuasca and other psychedelics affect depression and anxiety outcomes and adverse drug reactions, comparing single versus multiple dosing sessions.", "results_summary": "The study found that Ayahuasca, along with psilocybin and LSD, produced significant, rapid, and sustained improvements in anxiety and depression, with greater efficacy observed in multiple dosing sessions compared to single sessions. Adverse drug reactions were noted but did not outweigh the therapeutic benefits.", "population_specificity": "Subjects with known anxiety or depression.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:40.983087+00:00"}
{"study_id": 57973, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to summarize and analyze registered clinical studies evaluating the therapeutic effects of psychedelics, including ayahuasca, on psychiatric disorders.", "results_summary": "Ayahuasca was investigated for its therapeutic effects on post-traumatic stress disorder (PTSD) and major depressive disorder (MDD), but only a small fraction (1.4%) of registered studies focused on it. Results from these studies were not detailed in the abstract.", "population_specificity": "Patients with PTSD and MDD.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:41.972725+00:00"}
{"study_id": 57976, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to review toxicological aspects, traditional use/therapeutic potential, and analytical methods for detecting natural psychoactive substances, including Ayahuasca, in biological matrices.", "results_summary": "The abstract does not provide specific findings about Ayahuasca's effects but highlights concerns about the health risks of abusive consumption and the need for better analytical detection methods.", "population_specificity": "Not specified", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:42.028450+00:00"}
{"study_id": 57975, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the safety, efficacy, and neurobiological mechanisms of psychedelic drugs, including ayahuasca, for treating mental disorders such as major depression.", "results_summary": "The abstract indicates that clinical trials have assessed ayahuasca's therapeutic potential, suggesting it may be effective as an adjuvant in psychotherapeutic processes, though specific results are not detailed.", "population_specificity": "Patients with mental disorders, including major depression (specific demographics not provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:42.737802+00:00"}
{"study_id": 57977, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to identify clinical and biological factors that predict response to psychedelics, including Ayahuasca, in psychiatric and addictive disorders.", "results_summary": "The study found that the intensity of the acute psychedelic experience was the main predictive factor of response across multiple disorders, including alcohol and tobacco use disorders, treatment-resistant depression, and anxiety/depressive symptoms in cancer patients, but not for obsessive-compulsive disorder.", "population_specificity": "Patients with addictive disorders, treatment-resistant depression, obsessive-compulsive disorder, and depressive/anxiety symptoms in life-threatening cancer.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:43.228982+00:00"}
{"study_id": 57979, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to review the potential therapeutic mechanisms and clinical efficacy of psychedelics, including ayahuasca, in treating substance use disorders and unipolar depression.", "results_summary": "The abstract highlights promising but methodologically limited clinical trials on psychedelics, including ayahuasca, for psychiatric conditions, emphasizing the need for larger, controlled studies to confirm efficacy and understand mechanisms.", "population_specificity": "Patients with substance use disorders and unipolar depression (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:46.090880+00:00"}
{"study_id": 57981, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine and aggregate findings on how classic psychedelics, including ayahuasca, modulate memory in humans, focusing on both impairments in memory tasks and enhancements in autobiographical memory.", "results_summary": "Classic psychedelics dose-dependently impair memory task performance (e.g., spatial, verbal working memory) but enhance the vividness and recall of autobiographical memories, often those with strong emotional valence. Experienced users may show less impairment in memory tasks.", "population_specificity": "Humans (specific demographics not detailed in abstract)", "effective_dosage": "Not specified (dose-dependent effects noted)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:48.272481+00:00"}
{"study_id": 57980, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the clinical effects of classic serotonergic psychedelics, including ayahuasca, on mood state and depressive symptoms in both healthy and clinical populations.", "results_summary": "The study found that ayahuasca, along with other psychedelics, showed moderate significant effect sizes in improving acute and longer-term mood outcomes, particularly in patients with mood disorders. The effects were noted as fast-acting and enduring.", "population_specificity": "Healthy volunteers and patients with mood disorders (n=257 total, with 133 patients).", "effective_dosage": "Not specified for ayahuasca.", "study_duration": "Acute effects assessed 3h to 1 day post-treatment; longer-term effects assessed 16 to 60 days post-treatment.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:48.880289+00:00"}
{"study_id": 57983, "supplement_id": 902, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to quantify the psychological effects of ayahuasca in the post-acute period and evaluate its therapeutic potential across various outcome domains.", "results_summary": "Ayahuasca showed significant positive effects on psychiatric symptoms, affect-related measures, social outcomes, and existential/spiritual outcomes, with large effect sizes. No evidence of post-acute adverse effects was found.", "population_specificity": "Clinical and non-clinical samples (n = 549 across 24 unique samples).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Mean longest follow-up = 55.34 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:49.575159+00:00"}
{"study_id": 57986, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "To synthesize qualitative patient experiences of psychedelic treatments, including Ayahuasca, for mental disorders and identify common therapeutic processes.", "results_summary": "Patients reported comparable therapeutic experiences with Ayahuasca, including insights, altered self-perception, increased connectedness, and expanded emotional spectrum, contributing to clinically relevant responses. The study highlighted phenomenological similarities across different psychedelics and disorders.", "population_specificity": "Patients with mental disorders (e.g., anxiety, depression, PTSD, substance use disorders).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:50.289136+00:00"}
{"study_id": 57982, "supplement_id": 902, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to review the therapeutic potential and safety of Ayahuasca, focusing on its anti-inflammatory and neuroprotective effects in neurological and psychiatric disorders.", "results_summary": "The study found that Ayahuasca has therapeutic effects on behavioral disorders due to its inhibition of monoamine oxidase and activation of 5-hydroxytryptamine receptors, with additional anti-inflammatory properties linked to dimethyltryptamines. It was deemed very safe, as extremely high doses are required to reach toxicity, though further studies are needed to confirm these findings.", "population_specificity": "Indigenous groups, populations of Amazonian countries, and general clinical/preclinical study participants.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:50.613641+00:00"}
{"study_id": 57984, "supplement_id": 902, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review clinical studies on the therapeutic effects of serotonergic psychedelics, including Ayahuasca, for mental health conditions, focusing on efficacy, safety, and long-term effects.", "results_summary": "The study found promising early evidence of Ayahuasca's efficacy in treating depression and anxiety, with long-lasting therapeutic effects after 1 to 3 sessions. No severe adverse events were reported, and safety was established within controlled settings.", "population_specificity": "Patients with cancer- or illness-related anxiety and depression disorders (C/I-RADD), major depressive disorder (MDD), obsessive-compulsive disorder (OCD), or substance use disorder (SUD).", "effective_dosage": "Not specified", "study_duration": "Effects were observed weeks to months after 1 to 3 treatment sessions.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:51.035751+00:00"}
{"study_id": 57988, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the impact of ayahuasca on personality traits, particularly agreeableness, neuroticism, and openness, in a traditional ceremonial setting for ayahuasca tourists.", "results_summary": "The study found significant increases in agreeableness and reductions in neuroticism post-ayahuasca administration, sustained at 6-month follow-up, with trait-level increases in openness also observed. Greater mystical experiences were associated with greater reductions in neuroticism.", "population_specificity": "Ayahuasca tourists participating in traditional ceremonies.", "effective_dosage": "Not specified", "study_duration": "Single administration with follow-up at 6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:52.618521+00:00"}
{"study_id": 57992, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to summarize the clinical evidence on psychedelic drugs, including ayahuasca, for treating psychiatric disorders.", "results_summary": "The study found that research on ayahuasca is observational but suggests potential therapeutic effects for specific psychiatric disorders, though evidence remains preliminary.", "population_specificity": "Not specified (general psychiatric disorder context).", "effective_dosage": "Not available.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:52.733883+00:00"}
{"study_id": 57993, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review contemporary human studies on the use of psychedelic drugs, including ayahuasca, for treating psychiatric illnesses such as treatment-resistant depression, PTSD, and substance use disorders.", "results_summary": "The abstract suggests that psychedelics, including ayahuasca, show promise as breakthrough therapies for psychiatric conditions resistant to conventional treatments, though safety and efficacy details are not specified.", "population_specificity": "Patients with psychiatric illnesses (e.g., treatment-resistant depression, PTSD, substance use disorders).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:55.361395+00:00"}
{"study_id": 57995, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore how psychoactive drugs like ayahuasca can be integrated into the polypharmacology paradigm for treating psychiatric and neurological disorders.", "results_summary": "The study highlights ayahuasca's potential as a multi-target ligand with therapeutic benefits for complex CNS disorders, though it does not provide specific clinical outcomes.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:55.727135+00:00"}
{"study_id": 57997, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to review the psychotherapeutic uses of hallucinogens, including ayahuasca, in treating psychiatric disorders.", "results_summary": "The study found that ayahuasca and other hallucinogens showed significant associations with improvement in psychiatric conditions, though definitive conclusions were hindered by small sample sizes, inconsistent measures, and poor study design.", "population_specificity": "Individuals with psychiatric disorders (e.g., depression, substance use disorders, autism).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:57.458638+00:00"}
{"study_id": 57996, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to examine the rapid and sustained antidepressive, anxiolytic, and antiaddictive effects of serotoninergic hallucinogens, including Ayahuasca.", "results_summary": "The study found that Ayahuasca and similar compounds induce rapid and sustained antidepressive, anxiolytic, and antiaddictive effects, as observed in religious groups using Ayahuasca. These effects are linked to their agonist action on 5-HT receptors.", "population_specificity": "Religious groups using Ayahuasca (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:57.583461+00:00"}
{"study_id": 57999, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to compare the rapid-acting antidepressant effects of psychedelic drugs like ayahuasca with conventional antidepressants and other emerging treatments.", "results_summary": "The abstract suggests that ayahuasca, along with other psychedelics, may produce enduring antidepressant effects lasting many months, though clinical data are currently limited compared to other rapid-acting antidepressants like ketamine.", "population_specificity": "Not specified (general discussion of depressed patients, including treatment-resistant cases).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:57.984727+00:00"}
{"study_id": 57998, "supplement_id": 902, "safety_score": "80", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to determine the efficacy and tolerability of psychedelics, including ayahuasca, in managing resistant depression and anxiety.", "results_summary": "Ayahuasca, along with psilocybin and LSD, produced immediate and significant anti-depressant and anxiolytic effects that lasted several months, with good tolerability and only mild, transient adverse effects.", "population_specificity": "Patients with depression, anxiety, or both (total of 130 patients across seven studies).", "effective_dosage": "Not specified", "study_duration": "Several months (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:58.506643+00:00"}
{"study_id": 58001, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to assess the short-term therapeutic effects of an integrative SUD treatment program involving Ayahuasca and psychotherapy.", "results_summary": "The study found significant changes in clinical outcome variables between baseline and treatment completion, suggesting potential benefits of the integrative program for SUD. However, the abstract does not provide detailed statistical results or effect sizes.", "population_specificity": "53 males diagnosed with substance use disorder (SUD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:00.002507+00:00"}
{"study_id": 58000, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to review preclinical, observational, and preliminary clinical studies on ayahuasca's therapeutic potential for anxiety, mood disorders, and substance-use disorders, as well as its use in neuroscience research.", "results_summary": "The study found that ayahuasca shows promise in treating anxiety, mood disorders, and substance-use disorders, with preclinical and preliminary clinical studies supporting these findings. It also highlighted ayahuasca's utility in neuroscience for studying introspection and complex cognitive processes.", "population_specificity": "Native populations of the Northwestern Amazon and broader global populations where ayahuasca use has spread.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:00.677258+00:00"}
{"study_id": 58002, "supplement_id": 902, "safety_score": "80", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to assess the role of endogenous DMT and evaluate potential clinical applications of ayahuasca and DMT for psychiatric disorders.", "results_summary": "The study found that ayahuasca shows promising results in treating anxiety, depression, and substance dependence, with a good safety profile. The role of endogenous DMT remains unclear.", "population_specificity": "Not specified (general review of existing studies).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:02.498468+00:00"}
{"study_id": 58005, "supplement_id": 902, "safety_score": "70", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the efficacy, safety, and tolerability of ayahuasca and other serotonergic hallucinogens in treating mood, anxiety, and substance-use disorders.", "results_summary": "Ayahuasca reduced depression symptoms in treatment-resistant depression, but most studies had small sample sizes, short durations, and few randomized controlled trials (RCTs). The results were promising but require further validation with larger, longer-term RCTs.", "population_specificity": "Patients with treatment-resistant depression, cancer-related anxiety/depression, and alcohol/tobacco dependence.", "effective_dosage": "Not specified", "study_duration": "Short-term (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:04.210225+00:00"}
{"study_id": 58008, "supplement_id": 902, "safety_score": "70", "efficacy_score": 75, "quality_score": 65, "study_goal": "To review ayahuasca's behavioral effects, adverse effects, mechanisms of action, and potential clinical uses in mental illness.", "results_summary": "The study suggests ayahuasca may be useful for treating psychiatric disorders and addictions, with a relatively mild side effect profile, though more detailed studies are needed. It also highlights the need for relaxed government regulations to facilitate comprehensive clinical trials.", "population_specificity": "Not specified (review of existing literature)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:04.531117+00:00"}
{"study_id": 58009, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare psychedelic states (including those induced by ayahuasca) with night dreams and explore therapeutic applications in psychiatry.", "results_summary": "The study found significant overlaps between psychedelic states and dreaming, particularly in perception, emotion, and self-awareness, suggesting potential long-term psychosocial benefits. Differences included clarity of consciousness and metacognitive abilities, with psychedelic states resembling lucid dreaming.", "population_specificity": "Not specified (general review of literature)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:05.260190+00:00"}
{"study_id": 58012, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review EEG and brain imaging studies on psychedelics, including Ayahuasca, and evaluate their efficacy as adjunct therapy for psychiatric and addictive disorders.", "results_summary": "The study found that psychedelics, including Ayahuasca, appear effective in treating depression and alcohol-use disorders, based on EEG and brain imaging evidence.", "population_specificity": "Not specified (general review of studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:05.284900+00:00"}
{"study_id": 58011, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to analyze ayahuasca use in religious/spiritual networks as health care systems, focusing on Spain and Catalonia, and explore tensions between medicalization, prohibitionist policies, and its role as medicine.", "results_summary": "The study describes the emergence of ayahuasca groups in Catalonia and therapeutic itineraries of participants, highlighting tensions between medicalization, pluralism, and drug policies, but does not provide specific efficacy or safety outcomes.", "population_specificity": "Indigenous, mestizo, and international users in Spain/Catalonia, particularly within religious/spiritual networks.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:06.596627+00:00"}
{"study_id": 58014, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The abstract does not specify a research goal but mentions the expansion of Ayahuasca use for its psychotropic properties.", "results_summary": "The abstract does not provide specific study results, only noting the global expansion of Ayahuasca use due to its psychotropic effects.", "population_specificity": "Indigenous populations of the Amazon and worldwide users.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:08.164024+00:00"}
{"study_id": 58015, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to review scientific literature on tryptamines, including Ayahuasca, focusing on their structure, effects, pharmacology, toxicity, and reported fatalities.", "results_summary": "The study compiled existing information on tryptamines, noting their hallucinogenic properties and potential risks, including cases of death, but did not present new experimental data on Ayahuasca specifically.", "population_specificity": "Not specified (literature review)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:09.920201+00:00"}
{"study_id": 58013, "supplement_id": 902, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to systematically review human studies assessing Ayahuasca's effects on psychiatric symptoms, neuropsychological functioning, and neuroimaging to evaluate its safety and potential therapeutic benefits.", "results_summary": "Acute Ayahuasca use was well tolerated, improved mood and cognition, and showed antidepressive and antiaddictive potential. Long-term use was associated with enhanced mood, cognition, and spirituality without increased psychopathology or cognitive deficits.", "population_specificity": "Human subjects in studies from Northwestern Amazonian tribes to populations in Europe and the USA.", "effective_dosage": "Not specified", "study_duration": "Varied (acute, subacute, and long-term effects assessed)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:10.176334+00:00"}
{"study_id": 58017, "supplement_id": 902, "safety_score": "80", "efficacy_score": null, "quality_score": 60, "study_goal": "The researchers aimed to review the available data on the immunological impact of ayahuasca in humans.", "results_summary": "The abstract notes evidence of good tolerability and safety for ayahuasca in laboratory and ritual settings but highlights a lack of information on its immunological effects.", "population_specificity": "Not specified (general human use, including ritual and laboratory contexts).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:11.080441+00:00"}
{"study_id": 58018, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to review plant-based medicines, including ayahuasca, for their potential anxiolytic effects based on preclinical and clinical evidence.", "results_summary": "The abstract mentions ayahuasca as part of a broader discussion on psychotropic plant-based treatments for anxiety disorders, but specific results for ayahuasca are not detailed. The review highlights methodological limitations in some studies, such as small sample sizes and brief durations.", "population_specificity": "Not specified (general review of clinical and preclinical studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:12.474710+00:00"}
{"study_id": 58020, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the pharmacology of ayahuasca, focusing on harmine, and explore potential mechanisms for its reported reduction in recidivism to alcohol and cocaine misuse.", "results_summary": "The study suggests ayahuasca may improve mental health and reduce recidivism to alcohol and cocaine use, with proposed mechanisms including MAOI effects, 5-HT(2A) and imidazoline receptor interactions, and inhibition of DYRK1A and the dopamine transporter.", "population_specificity": "Not specified (general discussion, no specific population studied)", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:13.313819+00:00"}
{"study_id": 58019, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effects of ayahuasca-assisted therapy on problematic substance use and stress in a rural First Nations community.", "results_summary": "The study found statistically significant improvements in hopefulness, empowerment, mindfulness, and quality of life, along with reduced alcohol, tobacco, and cocaine use, though cannabis and opiate use remained unchanged. All participants reported positive and lasting changes from the therapy.", "population_specificity": "Rural First Nations community in British Columbia, Canada (12 participants).", "effective_dosage": "Not specified", "study_duration": "Four days of group counselling with two ayahuasca ceremonies, followed by six months of follow-up.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:13.479733+00:00"}
{"study_id": 58021, "supplement_id": 902, "safety_score": "75", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to investigate the physiological impact of ayahuasca, including autonomic, neuroendocrine, and immunomodulatory effects, compared to a placebo and d-amphetamine.", "results_summary": "Ayahuasca led to measurable DMT plasma levels, distinct subjective and neurophysiological effects, increased prolactin and cortisol levels, and time-dependent modifications in lymphocyte subpopulations, with effects peaking around 2 hours and returning to baseline by 24 hours.", "population_specificity": "10 healthy volunteers", "effective_dosage": "1.0 mg DMT/kg body weight (encapsulated freeze-dried ayahuasca)", "study_duration": "Single-dose intervention with follow-up at 2 and 24 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:15.314659+00:00"}
{"study_id": 58022, "supplement_id": 902, "safety_score": "75", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the human pharmacology of repeated ayahuasca doses and assess potential acute tolerance or sensitization.", "results_summary": "Two consecutive ayahuasca doses led to higher DMT plasma concentrations, subjective and neurophysiological effects, and increased prolactin and cortisol, but no clear tolerance or sensitization in psychological or most physiological variables. A trend toward reduced cardiovascular activation and significant tolerance to growth hormone secretion was observed.", "population_specificity": "Nine experienced psychedelic drug users.", "effective_dosage": "0.75 mg DMT/kg bodyweight, administered twice 4 hours apart.", "study_duration": "Single-day intervention with measures taken up to 12 hours after the first dose.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:16.914803+00:00"}
{"study_id": 190202, "supplement_id": 902, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review existing studies on drug-drug interactions between classic psychedelics (including ayahuasca) and other drugs in humans.", "results_summary": "The study identified limited data on ayahuasca, with only one report included. No serious adverse drug events were described in the included studies, though interactions with other drugs showed varied effects (attenuated, potentiated, or no change).", "population_specificity": "Humans (specific population not detailed in the abstract).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned (though the study broadly discusses interactions with antidepressants, antipsychotics, anxiolytics, mood stabilisers, and recreational drugs).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:18.524926+00:00"}
{"study_id": 2483, "supplement_id": 903, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of synthetic B vitamin supplements (pyridoxine, folic acid, and cyanocobalamin) on chronic heart failure severity markers and cardiac function.", "results_summary": "The study found that synthetic B vitamins slightly increased systolic, diastolic, and central venous pressure while reducing heart rate and improving left ventricular ejection fraction (LVEF). Thiamine acted as a vasodilator, reducing cardiac afterload and enhancing heart function.", "population_specificity": "150 individuals diagnosed with chronic heart failure and reduced left ventricular ejection fraction.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:18.533198+00:00"}
{"study_id": 2484, "supplement_id": 903, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the potential of fermented starchy and vegetable foods in sub-Saharan Africa to provide B-vitamins and examine techniques to prevent or enhance B-vitamin content before consumption.", "results_summary": "Fermentation improves B-vitamin content and bioavailability, but heat treatment can either enhance or degrade B-vitamins depending on the food. The study highlights methods to mitigate B-vitamin loss and enrich B-vitamins in processed foods.", "population_specificity": "Sub-Saharan African populations consuming fermented starchy and vegetable foods.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:18.745815+00:00"}
{"study_id": 2486, "supplement_id": 903, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the therapeutic potential of B vitamins, particularly the CompligamB complex, in addressing chronic pain and its associated systemic changes.", "results_summary": "The study suggests that the CompligamB complex, containing multiple B vitamins, inosine, and para-aminobenzoic acid, provides an additional therapeutic effect for chronic pain, with synergistic effects among the components.", "population_specificity": "Patients with chronic pain (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:20.769000+00:00"}
{"study_id": 2485, "supplement_id": 903, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the neuroprotective effects of a dietary supplement containing B Vitamins, forskolin, homotaurine, and spearmint extract in a mouse model of acute glaucoma, independent of intraocular pressure reduction.", "results_summary": "The supplement significantly increased retinal ganglion cell survival, reduced calpain activity, decreased caspase-3 and PARP-1 activation, and prevented GFAP upregulation, demonstrating neuroprotective effects independent of IOP-lowering.", "population_specificity": "Adult wild-type C57BL/6J mice with induced acute glaucoma.", "effective_dosage": "125 mg/kg/day (branded as Gangliomix\u00ae) administered by oral gavage.", "study_duration": "17 days (with ocular hypertension induced on the 10th day).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:21.574637+00:00"}
{"study_id": 2487, "supplement_id": 903, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop and validate a novel LC-MS/MS method for simultaneous quantification of 10 B vitamins in mouse colon tissue and assess their levels in mice with breast cancer after doxorubicin chemotherapy.", "results_summary": "The study successfully developed a validated LC-MS/MS method for detecting B vitamins in mouse colon tissue, demonstrating good linearity, accuracy, and precision. It revealed that doxorubicin treatment caused colon damage and accumulation of B1, B2, and B5 in mice.", "population_specificity": "Mice with breast cancer undergoing doxorubicin chemotherapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:22.458589+00:00"}
{"study_id": 2488, "supplement_id": 903, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the relationship between folate and related B vitamins, epigenetic mechanisms, and brain health outcomes across different life stages.", "results_summary": "The study suggests that optimal B vitamin status may support cognitive development in early life and prevent cognitive dysfunction later in life, potentially through folate-related DNA methylation. The EpiBrain project is analyzing existing cohorts and trials to better understand these mechanisms.", "population_specificity": "Pregnant women, children, and older adults.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:22.948679+00:00"}
{"study_id": 2489, "supplement_id": 903, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the relationship between serum B vitamin levels and breast cancer risk by comparing levels in healthy individuals, benign breast disease patients, and breast cancer patients.", "results_summary": "Higher levels of VitB1 and VitB5 were found in breast cancer and benign breast disease patients compared to healthy controls, while VitB3 levels were lower in breast cancer patients. VitB1 was positively correlated with breast cancer risk, VitB3 negatively correlated, and VitB5 showed no significant relationship.", "population_specificity": "520 attendees of Yunnan Cancer Hospital (38 benign breast disease patients, 87 breast cancer patients, 91 healthy controls).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:25.920203+00:00"}
{"study_id": 2492, "supplement_id": 903, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the role of microbiota in B vitamin provision for insects and ticks, focusing on specificity and redundancy of microbial contributions across life stages.", "results_summary": "The study highlights the essential role of microbiota in providing B vitamins to insects and ticks, emphasizing both specific symbionts and nonspecific microbes. It explores microbial vitamin provision during postembryonic development, adulthood, and reproduction.", "population_specificity": "Insects and ticks", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:26.959996+00:00"}
{"study_id": 2491, "supplement_id": 903, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether B vitamins interact with Pt (II) derivatives (e.g., cisplatin, oxaliplatin, carboplatin) similarly to DNA nucleobases, potentially influencing anti-cancer mechanisms.", "results_summary": "The study found that B vitamins interact spontaneously with mono- and diaqua derivatives of cisplatin and oxaliplatin, with diaqua derivatives showing stronger interactions. Carboplatin had the weakest interactions. Non-covalent interactions were confirmed, and theoretical and experimental results aligned well.", "population_specificity": "Not specified (theoretical and experimental study, no human subjects).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "Interactions with Pt (II) derivatives (cisplatin, oxaliplatin, carboplatin) were noted.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:27.411038+00:00"}
{"study_id": 2490, "supplement_id": 903, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "To determine if daily low-dose B vitamins plus betaine supplementation could reduce plasma homocysteine concentrations in Chinese adults with hyperhomocysteinemia.", "results_summary": "The supplement group showed a significant reduction in plasma homocysteine concentrations (10.1% reduction) after 12 weeks, with the decrease associated with increased folate and betaine levels. No significant differences were observed at baseline between groups.", "population_specificity": "Chinese adults aged 18-65 with hyperhomocysteinemia, free from mandatory folic acid fortification.", "effective_dosage": "400 \u03bcg folic acid, 8 mg vitamin B6, 6.4 \u03bcg vitamin B12, and 1 g betaine daily.", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:27.574097+00:00"}
{"study_id": 2493, "supplement_id": 903, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the association of B vitamins (riboflavin, niacin, pantothenic acid, vitamin B6, folate, and MMA as a marker for B12) with IVF-ET outcomes.", "results_summary": "Higher riboflavin levels were linked to increased probabilities of high-quality embryos and clinical pregnancy, while middle tertile folate levels correlated with transferable embryos. Serum MMA (indicating B12 deficiency) negatively correlated with high-quality embryos; other vitamins showed no significant effects.", "population_specificity": "216 women aged <35 years undergoing their first oocyte retrieval cycle for IVF-ET.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:29.891652+00:00"}
{"study_id": 2494, "supplement_id": 903, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the evidence on B vitamins' effects on fertility, particularly in women with PCOS, and assess the potential benefits of supplementation.", "results_summary": "The study found strong evidence that B vitamins, especially folate and B12, improve fecundability and fertility, with potentially greater effects in women with menstrual cycle dysfunction (e.g., PCOS). Folic acid supplementation in PCOS women may reduce homocysteine levels and improve metabolic profiles, though direct fertility outcomes were not measured.", "population_specificity": "Women, particularly those with polycystic ovary syndrome (PCOS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:30.233984+00:00"}
{"study_id": 2496, "supplement_id": 903, "safety_score": "Not Assessed", "efficacy_score": 40, "quality_score": 70, "study_goal": "The researchers aimed to assess the current evidence on the role of B vitamins in bone health, particularly their impact on homocysteine concentrations and bone-related outcomes.", "results_summary": "Clinical trials indicate that B vitamins affect homocysteine concentrations, but most studies found no significant effect on bone turnover markers, bone mineral density, or fracture risk. The evidence remains inconsistent, requiring further research to clarify the mechanisms and effects.", "population_specificity": "Humans (specific demographics not detailed in the abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:30.863406+00:00"}
{"study_id": 2495, "supplement_id": 903, "safety_score": "85", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of low-dose B vitamin supplementation on clinical and biochemical parameters in critically ill COVID-19 patients.", "results_summary": "Vitamin B supplementation showed no significant effects on biochemical or pathological parameters but was associated with a non-significant reduction in 30-day mortality (83.3% vs. 96.1%, P = 0.07). The study concluded that low-dose B vitamins might improve mortality rates in COVID-19 patients.", "population_specificity": "Critically ill COVID-19 patients (n = 85).", "effective_dosage": "Thiamine (10 mg), riboflavin (4 mg), nicotinamide (40 mg), and dexpanthenol (6 mg) daily.", "study_duration": "2 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:31.915690+00:00"}
{"study_id": 2500, "supplement_id": 903, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine the effectiveness and potential harm of B-vitamin therapy in reducing chemotherapy-induced side effects in cancer patients.", "results_summary": "Vitamin B6 showed no significant impact on reducing chemotherapy-induced side effects, dose modifications, or improving quality of life and survival. Vitamin B12 may alleviate some neuropathy symptoms, but combined B vitamins did not reduce neuropathy incidence.", "population_specificity": "1546 cancer patients undergoing chemotherapy with diverse cancer types.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:35.571259+00:00"}
{"study_id": 2498, "supplement_id": 903, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether a combination of B vitamins with green tea, rhodiola, and magnesium could enhance spectral brain activity during attentional tasks under stress.", "results_summary": "The combined treatment (Mg + B vitamins + green tea + rhodiola) significantly increased frontal midline theta activity during attention tasks and theta activation in response to emotionally threatening images, suggesting improved attentional capacity under stress. No significant effects were observed on behavioral performance or event-related potentials.", "population_specificity": "100 moderately stressed adults", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:36.015269+00:00"}
{"study_id": 2497, "supplement_id": 903, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of a B vitamin complex (Neuromultivit) combined with celecoxib compared to meloxicam for treating acute and chronic nonspecific lumbar pain.", "results_summary": "The combination of celecoxib and Neuromultivit showed more pronounced relief of both acute and chronic pain syndromes and improved motor function compared to celecoxib alone or meloxicam. The effects were statistically significant, with complete pain relief achieved in 60.22% of cases by day 21.", "population_specificity": "93 patients (61.3% women, 38.7% men; average age 49.9\u00b19 years) with nonspecific lumbar pain due to spondyloarthrosis of the lumbosacral spine.", "effective_dosage": "Not specified", "study_duration": "21 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:36.417417+00:00"}
{"study_id": 2499, "supplement_id": 903, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of a light breakfast on serum concentrations of metabolites and B-vitamins related to one-carbon metabolism.", "results_summary": "The study found that a light breakfast with low nutrient content significantly altered serum concentrations of several metabolites and B-vitamins, decreasing some (e.g., homocysteine, flavin mononucleotide) and increasing others (e.g., choline, folate).", "population_specificity": "Sixty-three healthy adults (36 women) with BMI \u2265 27 kg/m\u00b2.", "effective_dosage": "Not specified (meal contained low amounts of B-vitamins).", "study_duration": "Blood collected at fasting, 60, and 120 minutes post-meal.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:37.005900+00:00"}
{"study_id": 2502, "supplement_id": 903, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to compare the effectiveness of B vitamin injections against other treatments (informative treatment, oral cavity probiotics, and low-level laser therapy) for improving quality of life in patients with burning mouth syndrome.", "results_summary": "The study found that B vitamin injections were less effective than oral cavity probiotics and low-level laser therapy in improving quality of life, as measured by the OHIP-14 questionnaire. No statistically significant improvement was reported for B vitamin injections compared to other treatments.", "population_specificity": "New patients diagnosed with burning mouth syndrome.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:39.003753+00:00"}
{"study_id": 2501, "supplement_id": 903, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to examine the effects of thiamine (B1), pyridoxine (B6), cobalamin (B12), folic acid (B9), and a combination of these vitamins on women with episodic migraine (EM).", "results_summary": "The study found that supplementation with B vitamins significantly reduced the frequency of headache attacks, improved migraine disability scores, and decreased the use of abortive drugs compared to placebo. These effects were consistent across all vitamin groups.", "population_specificity": "120 women with episodic migraine (EM).", "effective_dosage": "1 capsule daily (specific amounts not detailed in the abstract).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:39.791795+00:00"}
{"study_id": 2503, "supplement_id": 903, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to identify which blood biochemical indicators, particularly B vitamins (thiamine, folate, vitamin B12), are most closely associated with cognitive decline and malnutrition in Alzheimer's disease patients.", "results_summary": "The study found that thiamine diphosphate (TDP) was significantly associated with malnutrition indicators and free triiodothyronine (FT3) levels, which are linked to cognitive decline in AD patients. Correcting thiamine metabolism was suggested as a potential therapeutic target for AD treatment.", "population_specificity": "206 Alzheimer's disease patients recruited from six hospitals in China.", "effective_dosage": "Not specified", "study_duration": "Not specified (cross-sectional study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:40.358372+00:00"}
{"study_id": 2504, "supplement_id": 903, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of B vitamins and vitamin D as adjuvants in improving standard treatment for depression and anxiety disorders and to gather evidence for clinical supplementation recommendations.", "results_summary": "Supplementation with folic acid, L-methylfolate, B1, B12, methylcobalamin, and vitamin D significantly reduced depression scores, either as monotherapy or alongside standard pharmacological treatment, including partial or complete remission. Limited evidence supported vitamin D's role in alleviating anxiety symptoms.", "population_specificity": "Adults \u226518 years diagnosed with major depressive disorder (MDD), generalized anxiety disorder (GAD), or mild to severe depressive/anxiety symptoms.", "effective_dosage": "Different doses (not specified in abstract)", "study_duration": "Varying study durations (not specified in abstract)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:42.080561+00:00"}
{"study_id": 2505, "supplement_id": 903, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to assess the value of B vitamin supplementation in the treatment of heart failure, focusing on their role in energy metabolism and potential therapeutic effects.", "results_summary": "The abstract suggests that B vitamins are linked to energy metabolism and that HF patients often have deficiencies, but it does not provide specific results on the efficacy of supplementation. The review highlights the potential of B vitamins as a therapeutic strategy but does not present conclusive findings.", "population_specificity": "Heart failure patients, particularly in aging populations in industrialized countries.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:44.023197+00:00"}
{"study_id": 2508, "supplement_id": 903, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to validate whether B vitamins improve global cognitive functioning and slow brain atrophy in older people with mild cognitive impairment (MCI), and to examine potential interactions with aspirin.", "results_summary": "B vitamins significantly reduced whole brain atrophy rate but had no significant effect on cognitive function scores. Aspirin use negatively interacted with B vitamins, diminishing their benefits on cognitive functioning and brain atrophy in aspirin users.", "population_specificity": "Older people with mild cognitive impairment (MCI)", "effective_dosage": "Not specified", "study_duration": "24 months", "interactions": "Negative interaction with aspirin", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:45.507287+00:00"}
{"study_id": 2506, "supplement_id": 903, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine the impact of prenatal B-vitamin supplementation on human milk B-vitamin concentrations and its adequacy for infant growth.", "results_summary": "Prenatal supplementation did not affect human milk B-vitamin concentrations at 2-weeks postpartum, with site-specific differences observed. Vitamin B2 and B6 levels in human milk were frequently below deficiency thresholds, but no association with infant growth was found.", "population_specificity": "200 women from Guatemala, India, and Pakistan, randomized into pre-conception, prenatal, or no supplementation groups.", "effective_dosage": "Lipid-based nutrient supplement (specific B-vitamin dosages not detailed).", "study_duration": "Average of 15.7 months (pre-conception arm) and 6.0 months (prenatal arm).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:45.992317+00:00"}
{"study_id": 2507, "supplement_id": 903, "safety_score": "90", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to compare the efficacy and safety of two treatment regimens (Texared/Neurobion vs. Amelotex/Milgamma) in patients with acute dorsalgia, focusing on pain reduction and overall well-being.", "results_summary": "Both treatment groups showed comparable improvements in pain and sleep quality, but the Texared/Neurobion group demonstrated more pronounced pain reduction by the 3rd visit and better general well-being. Patient and doctor assessments rated both therapies similarly effective, with no significant adverse events reported.", "population_specificity": "70 patients with acute lumbar dorsalgia (average age ~50-53 years, ~70% female).", "effective_dosage": "Not specified in the abstract.", "study_duration": "The intervention was assessed up to the 3rd visit, but exact duration is not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:47.353780+00:00"}
{"study_id": 2509, "supplement_id": 903, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 30, "study_goal": "The researchers aimed to determine whether methylated B vitamins could improve symptoms in a patient with postural orthostatic tachycardia syndrome (POTS) refractory to conventional treatment, particularly in the context of a catechol-O-methyltransferase (COMT) polymorphism.", "results_summary": "The patient, who was unresponsive to standard treatments, showed improvement after receiving methylated B vitamins, suggesting a potential benefit for POTS patients with the COMT Val158Met polymorphism.", "population_specificity": "A middle-aged woman with POTS and heterozygous COMT Val158Met polymorphism.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:47.719510+00:00"}
{"study_id": 2510, "supplement_id": 903, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "To determine if B vitamin treatment reduces cognitive impairment linked to high-fat diets in rats and modulates transketolase (TK) expression and activity.", "results_summary": "B vitamin supplementation improved cognitive performance in rats on high-fat diets and increased TK expression in erythrocytes and hypothalamus compared to untreated controls. The combined B vitamin regimen (H3) showed the most significant effects.", "population_specificity": "Rats fed high-fat diets", "effective_dosage": "H1: 100 mg/kg BW thiamine, 100 mg/kg BW riboflavin, 250 mg/kg BW niacin daily; H2: 100 mg/kg BW pyridoxine, 100 mg/kg BW cobalamin, 5 mg/kg BW folate daily; H3: combined H1 and H2 regimens daily", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:49.989529+00:00"}
{"study_id": 115235, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness and long-term benefits of bariatric surgery for severe obesity and its impact on obesity-related comorbid diseases and mortality.", "results_summary": "Bariatric surgery was found to be the most effective and durable treatment for severe obesity, significantly improving or resolving obesity-related comorbid diseases and reducing all-cause mortality, particularly through decreases in cancer, diabetes, and cardiovascular-related mortality.", "population_specificity": "Patients with severe obesity.", "effective_dosage": "Not specified", "study_duration": "Long-term (specific duration not mentioned)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:58.016745+00:00"}
